{"gene":"CAVIN1","run_date":"2026-04-28T17:28:52","timeline":{"discoveries":[{"year":1998,"finding":"PTRF (Cavin1) was cloned and shown to dissociate paused RNA Polymerase I ternary transcription complexes in vitro by releasing both nascent pre-rRNA transcripts and Pol I from the template; it interacts with TTF-I, Pol I, and the 3' end of pre-rRNA, with 3'-terminal uridylates essential for binding and release activity.","method":"In vitro transcription release assay with recombinant PTRF, protein–protein interaction studies, RNA-binding assay with 3'-end mutants","journal":"The EMBO journal","confidence":"High","confidence_rationale":"Tier 1 — reconstituted in vitro activity with mutagenesis validation","pmids":["9582279"],"is_preprint":false},{"year":1999,"finding":"PTRF interacts with the largest subunit of RNA Polymerase I and promotes dissociation of paused ternary transcription complexes through conserved interactions with Pol I and the termination factors TTF-I/Reb1p, but cannot release Pol I stalled by a non-termination factor (lac repressor), establishing specificity for termination-factor-dependent pausing.","method":"In vitro transcription termination assay using immobilized tailed templates from yeast and mouse; protein–protein interaction studies","journal":"Molecular & general genetics","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with cross-species validation","pmids":["10589839"],"is_preprint":false},{"year":2001,"finding":"PTRF-mediated transcript release facilitates reinitiation of RNA Polymerase I transcription, thereby augmenting ribosomal RNA synthesis; PTRF is phosphorylated at multiple sites and fractionates into transcriptionally active and inactive forms, suggesting phosphorylation regulates its activity.","method":"Multiple-round and single-round in vitro transcription assays; reconstituted PTRF-free transcription system; phosphorylation analysis","journal":"Nucleic acids research","confidence":"High","confidence_rationale":"Tier 1 — reconstitution in PTRF-free system with multiple orthogonal assays","pmids":["11139612"],"is_preprint":false},{"year":2004,"finding":"PTRF is a major protein at the cytosolic surface of caveolae in human adipocytes, is phosphorylated at Ser-36, Ser-40, Ser-365, and Ser-366, and is subject to calpain-mediated cleavage at two sites within PEST domains, producing multiple truncated forms; co-localization with caveolin confirmed by immunofluorescence.","method":"Vectorial proteomics (differential proteolysis + MS on sealed caveolar vesicles), nanospray-quadrupole-TOF MS, immunofluorescence confocal microscopy","journal":"The Biochemical journal","confidence":"High","confidence_rationale":"Tier 1-2 — multiple orthogonal methods including MS-based phosphosite mapping on native protein","pmids":["15242332"],"is_preprint":false},{"year":2008,"finding":"PTRF/Cavin1 is required for caveola formation and for sequestration of caveolin into immobile caveolae at the plasma membrane; without PTRF, caveolin resides on flat plasma membrane with increased lateral mobility and undergoes accelerated lysosomal degradation; expression of PTRF in caveolae-deficient PC3 cells is sufficient to induce caveola formation.","method":"Comparative proteomics, siRNA knockdown, ectopic expression in PC3 cells, zebrafish knockdown, FRAP, electron microscopy, live imaging","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods, in vitro and in vivo rescue, replicated in two model systems","pmids":["18191225"],"is_preprint":false},{"year":2008,"finding":"Global deletion of Cavin1 in mice abolishes morphologically detectable caveolae in all cell types and markedly reduces protein expression of all three caveolin isoforms (while caveolin mRNA remains normal or elevated), demonstrating Cavin1 is essential for caveolae formation and post-translational stabilization of caveolins.","method":"Targeted gene disruption in mice, electron microscopy, immunoblotting, qRT-PCR","journal":"Cell metabolism","confidence":"High","confidence_rationale":"Tier 2 — clean knockout mouse with multiple phenotypic readouts and molecular mechanism","pmids":["18840361"],"is_preprint":false},{"year":2009,"finding":"Human PTRF mutations cause secondary deficiency and mislocalization of all three caveolin family members; disease-associated mutations cause PTRF mislocalization and disrupt its physical interaction with caveolins, confirming PTRF is required for caveolae formation and proper caveolin localization in human cells.","method":"Patient muscle biopsy analysis, ectopic expression of mutant PTRF constructs in myoblasts, co-immunoprecipitation, immunofluorescence","journal":"The Journal of clinical investigation","confidence":"High","confidence_rationale":"Tier 2 — human genetics plus functional validation with reciprocal interaction and localization studies","pmids":["19726876"],"is_preprint":false},{"year":2010,"finding":"In patient fibroblasts lacking PTRF, caveolin-1 fails to localize to the cell surface and caveolae are reduced to <3%; transfection of full-length PTRF re-establishes caveolae, confirming the essential and sufficient role of PTRF in caveola biogenesis.","method":"Patient fibroblast analysis, electron microscopy, Atomic Force Microscopy, transfection rescue","journal":"PLoS genetics","confidence":"High","confidence_rationale":"Tier 2 — rescue experiment with multiple imaging modalities in human patient cells","pmids":["20300641"],"is_preprint":false},{"year":2010,"finding":"PTRF/Cavin1 expression in PC3 prostate cancer cells reduces cell migration via decreased MMP9 production, and this effect is independent of caveola formation.","method":"Ectopic expression of PTRF in PC3 cells, cell migration assays, MMP9 ELISA/zymography","journal":"European journal of cell biology","confidence":"Medium","confidence_rationale":"Tier 2-3 — loss-of-function/gain-of-function with defined molecular readout; caveola-independence demonstrated by comparison","pmids":["20732728"],"is_preprint":false},{"year":2010,"finding":"PTRF/Cavin1 interacts with the BFCOL1 zinc-finger transcription factor and enhances its binding to the mouse proalpha2(I) collagen proximal promoter in vitro, while suppressing promoter activity in transient transfection assays, indicating a role for PTRF in RNA Pol II transcription regulation.","method":"Yeast two-hybrid screening, in vitro EMSA, transient transfection reporter assay","journal":"The Biochemical journal","confidence":"Medium","confidence_rationale":"Tier 2 — two orthogonal methods (interaction + functional assay) in a single study","pmids":["10727401"],"is_preprint":false},{"year":2011,"finding":"PTRF acts as a docking protein for MG53 at plasma membrane injury sites, potentially by binding exposed membrane cholesterol; cells lacking PTRF show defective MG53 trafficking to injury sites, and a disease-associated PTRF mutation causes aberrant nuclear localization of PTRF and disrupts MG53-mediated membrane resealing; overexpression of PTRF rescues membrane repair defects in dystrophic muscle.","method":"RNAi knockdown, ectopic expression with mutant PTRF, live imaging of membrane repair, co-immunoprecipitation, fluorescence microscopy","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods including KD, mutant expression, live-cell imaging, and rescue","pmids":["21343302"],"is_preprint":false},{"year":2011,"finding":"PTRF/Cavin1 expression is increased in senescent fibroblasts; PTRF overexpression induces cellular senescence via sequestration of Mdm2 into caveolar membranes away from p53, activating the p53/p21 pathway; a caveola-membrane-targeting-deficient PTRF mutant fails to activate p53 or senescence, and PTRF translocates from nucleus to cytosol/plasma membrane during senescence.","method":"Overexpression and shRNA knockdown, immunofluorescence, electron microscopy, luciferase reporter assay, subcellular fractionation, mutant PTRF expression","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods with mechanistic mutant validation","pmids":["21705337"],"is_preprint":false},{"year":2011,"finding":"PTRF/Cavin1 localizes to nuclei of young/quiescent fibroblasts and translocates to cytosol and plasma membrane during cellular senescence; the role of PTRF in senescence is dependent on its targeting to caveolae and interaction with caveolin-1, regulated by PTRF phosphorylation.","method":"Immunofluorescence, electron microscopy, overexpression/knockdown, phosphorylation analysis","journal":"Cell research","confidence":"Medium","confidence_rationale":"Tier 2-3 — localization with functional link, but interaction with caveolin-1 not fully validated by co-IP","pmids":["21445100"],"is_preprint":false},{"year":2011,"finding":"PTRF expression modulates cholesterol distribution and impairs recruitment of actin cytoskeletal proteins to detergent-resistant membranes, leading to reduced prostasome secretion and decreased secretion of a subset of proteins including proteases, cytokines, and growth regulatory proteins.","method":"SILAC quantitative proteomics, subcellular fractionation, detergent-resistant membrane isolation, cholesterol modulation","journal":"Molecular & cellular proteomics","confidence":"Medium","confidence_rationale":"Tier 2 — quantitative proteomics with biochemical fractionation, single lab","pmids":["22030351"],"is_preprint":false},{"year":2012,"finding":"PTRF/Cavin1 co-regulates cell polarization and migration with caveolin-1; PTRF modulates subcellular localization of Rac1, caveolin-1, and PKCα caveola recruitment in migrating cells; PTRF quantitatively reduces cell migration and induces mesenchymal-to-epithelial reversion, with caveola-independent functions identified.","method":"Fluorescence imaging, quantitative proteomics, cell migration assays, selective manipulation of PTRF and caveolin-1 expression in multiple cell systems","journal":"PloS one","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple cell systems and orthogonal methods, single lab","pmids":["22912783"],"is_preprint":false},{"year":2013,"finding":"PTRF/Cavin1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer; cavin-1 co-expression reverses the oncogenic effects of caveolin-1 in caveolin-1-positive cells; absence of cavin-1 in advanced prostate cancer allows caveolin-1 to reside outside caveolae in tumor-promoting microdomains; cavin-1 reduces IL-6 microenvironmental function.","method":"Tissue microarray, ectopic expression in PC3/LNCaP/22Rv1 cells, anchorage-independent growth assays, orthotopic xenograft mouse model","journal":"Oncogene","confidence":"Medium","confidence_rationale":"Tier 2-3 — in vitro and in vivo functional assays with mechanistic pathway placement","pmids":["23934189"],"is_preprint":false},{"year":2014,"finding":"PTRF/Cavin1 promotes efficient rRNA transcription in response to metabolic challenges in mature adipocytes; multiple post-translational modifications of PTRF provide mechanistic bases for its regulation of rDNA transcription; this caveolae-independent nuclear function explains the lipodystrophy phenotype in PTRF-deficient mice and humans.","method":"rDNA transcription assays in mature adipocytes, analysis in PTRF-deficient mice, post-translational modification mapping","journal":"eLife","confidence":"High","confidence_rationale":"Tier 2 — multiple orthogonal methods linking PTMs to rDNA transcription function","pmids":["27528195"],"is_preprint":false},{"year":2014,"finding":"SOCS3 localizes to the plasma membrane through interaction with cavin-1; deletion of SOCS3 reduces cavin-1 and caveolin-1 protein expression and reduces caveola abundance in endothelial cells; the cavin-1/SOCS3 interaction is essential for SOCS3-dependent inhibition of IL-6 signaling by cyclic AMP.","method":"Biochemical interaction studies, confocal imaging, SOCS3 knockout cells, cytokine signaling assays","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — reciprocal interaction and functional epistasis with multiple methods","pmids":["29330478"],"is_preprint":false},{"year":2015,"finding":"Cavin3 is targeted to caveolae by cavin1 where it interacts with the scaffolding domain of caveolin1 to promote caveolae dynamics; the N-terminal region of cavin3 binds a trimer of the cavin1 N-terminus in competition with cavin2, demonstrating distinct subcomplexes; loss of cavin3 increases stable caveolae and decreases transiently membrane-associated caveolae.","method":"Co-immunoprecipitation, TIRF/live-cell imaging, N-terminal binding competition assays, cavin3 KD cells","journal":"Journal of cell science","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP plus live imaging with functional consequence","pmids":["25588833"],"is_preprint":false},{"year":2016,"finding":"Purified Cavin1 forms 60S complexes that adopt a flexible, net-like protein mesh forming polyhedral lattices on phosphatidylserine-containing vesicles; the two coiled-coil domains mediate distinct assembly steps; positive residues around the C-terminal coiled-coil domain are required for membrane binding; caveolin 8S oligomers form disc-shaped arrangements consistent with occupying the faces of caveolar polyhedra.","method":"Electron cryotomography, in vitro reconstitution on liposomes, coiled-coil domain mutagenesis, purified protein structural analysis","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 1 — reconstitution, structural analysis by cryo-ET, and mutagenesis in one study","pmids":["27834731"],"is_preprint":false},{"year":2016,"finding":"ROR1 functions as a scaffold for cavin-1 and caveolin-1 at the plasma membrane in a kinase-independent manner, facilitating their interaction and preventing lysosomal degradation of caveolin-1, thereby sustaining caveolae structures and pro-survival AKT signaling.","method":"Co-immunoprecipitation, immunofluorescence, ROR1 mutant expression, lysosomal inhibitor experiments","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 2 — reciprocal Co-IP, kinase-dead mutant, multiple inhibitor experiments","pmids":["26725982"],"is_preprint":false},{"year":2014,"finding":"The N-terminal leucine-zipper motif of PTRF/Cavin1 is essential and sufficient for its caveolae association at the plasma membrane, counteracting its nuclear localization sequence (AA 235-251); deletion of this motif causes exclusive nuclear localization; caveolae-associated PTRF is required for its role in cell migration.","method":"Deletion mutant expression, live-cell fluorescence imaging, fusion protein nuclear export assay, MEF migration assay with PTRF mutant rescue","journal":"Biochemical and biophysical research communications","confidence":"Medium","confidence_rationale":"Tier 2-3 — domain mutagenesis with functional consequence, single lab","pmids":["25514038"],"is_preprint":false},{"year":2019,"finding":"High glucose promotes LDL transcytosis across endothelial cells by inhibiting the AMPK-mTOR-PIK3C3 pathway, which suppresses CAV1-CAVIN1-LC3B-mediated autophagic degradation of CAV1, leading to CAV1 accumulation, more caveolae formation, and increased LDL transcytosis.","method":"siRNA knockdown, AMPK/mTOR/PIK3C3 pathway inhibition, LDL transcytosis assay, autophagy flux analysis, immunoblotting","journal":"Autophagy","confidence":"Medium","confidence_rationale":"Tier 2-3 — multiple pathway inhibition experiments with defined mechanistic sequence, single lab","pmids":["31448673"],"is_preprint":false},{"year":2019,"finding":"Cavin-1 is acutely translocated to focal complex compartments upon insulin stimulation, where it regulates focal complex formation through interaction with paxillin; loss of cavin-1 impairs focal complex remodeling and focal adhesion formation and causes a mechanical stress response with activation of proinflammatory and senescence/apoptosis pathways.","method":"Cavin-1 knockout mice, subcellular fractionation, immunoblotting, co-immunoprecipitation with paxillin, insulin stimulation assays","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — KO mouse with biochemical interaction identified, single lab","pmids":["31126986"],"is_preprint":false},{"year":2021,"finding":"Caveolin-1 and cavin1 individually sort distinct plasma membrane lipids; intact caveolar structures composed of both proteins generate a unique lipid nano-environment with selectivity for specific lipid headgroups and acyl chains.","method":"Quantitative nanoscale lipid mapping (STED-based), molecular dynamic simulations, genome-edited cells lacking CAV1 or cavin1","journal":"The Journal of cell biology","confidence":"High","confidence_rationale":"Tier 1-2 — quantitative nanoscale lipid mapping plus MD simulations in genome-edited cells","pmids":["33496726"],"is_preprint":false},{"year":2022,"finding":"PTRF/Cavin1 acts as a novel RNA-binding protein that stabilizes lncRNA NEAT1, which in turn suppresses UBXN1 and activates NF-κB, driving PD-L1 transcription and promoting immune evasion in glioblastoma.","method":"RIP-Seq, RIP assay, ChIP, co-immunoprecipitation, qRT-PCR, PD-L1 reporter assay","journal":"Frontiers in immunology","confidence":"Medium","confidence_rationale":"Tier 2-3 — RIP-Seq combined with ChIP and functional signaling assays, single lab","pmids":["35069587"],"is_preprint":false},{"year":2022,"finding":"Membrane insertion of Cavin1 occurs via PI(4,5)P2-dependent adsorption of the trimeric helical region 1 (HR1) followed by partial separation and membrane insertion of individual helices; insertion kinetics are enhanced by flanking negatively charged disordered regions important for co-assembly with Caveolin1 in living cells.","method":"Model membrane biophysics, liposome binding assays, computational modeling, mutagenesis, live-cell imaging of Cavin1-Caveolin1 co-assembly","journal":"PNAS","confidence":"High","confidence_rationale":"Tier 1 — in vitro reconstitution with model membranes, computational modeling, and validated in cells","pmids":["35696574"],"is_preprint":false},{"year":2022,"finding":"Oxidative stress triggers lipid peroxidation and caveolar disassembly, releasing CAVIN1 from caveolae; released cytoplasmic CAVIN1 directly interacts with NRF2 and facilitates its degradation, thereby maintaining cellular susceptibility to oxidative-stress-induced cell death (ferroptosis); CAVIN1-null cells show impaired NRF2 negative regulation and resistance to lipid-peroxidation-induced ferroptosis.","method":"Quantitative whole-cell proteomics of genome-edited CAVIN1-null cells, co-immunoprecipitation of CAVIN1–NRF2, live-cell caveolae imaging, zebrafish wound model","journal":"Developmental cell","confidence":"High","confidence_rationale":"Tier 2 — genome-edited cells, quantitative proteomics, reciprocal co-IP, in vivo zebrafish model","pmids":["36858041"],"is_preprint":false},{"year":2022,"finding":"Caveola deformation (by osmotic stress) causes relocalization of cavin-1 to the nucleus, altering global transcription and translation; cavin-1 levels affect cytosolic RNA levels and the ability to form stress granules and p-bodies; Cav1-Gαq contact changes upon stimulation also trigger cavin-1 relocalization.","method":"Osmotic stress experiments, cavin-1 KO cell line, live-cell imaging, stress granule/p-body quantification, RNA level analysis","journal":"The Journal of biological chemistry","confidence":"Medium","confidence_rationale":"Tier 2-3 — KO cell line with multiple phenotypic readouts, single lab","pmids":["35513070"],"is_preprint":false},{"year":2022,"finding":"UBE2O ubiquitinates PTRF/CAVIN1 directly and inhibits its effects on exosome secretion by decreasing caveolae formation; SDPR/CAVIN2 interacts with both UBE2O and PTRF and promotes PTRF expression in exosomes; UBE2O decreases exosome secretion and downregulates exosomal PTRF secretion.","method":"Exogenous and endogenous co-immunoprecipitation, ubiquitination assays, ultracentrifugation exosome isolation, nanoparticle tracking analysis, electron microscopy","journal":"Cell communication and signaling","confidence":"Medium","confidence_rationale":"Tier 2-3 — ubiquitination assay plus co-IP and functional exosome readouts, single lab","pmids":["36443833"],"is_preprint":false},{"year":2022,"finding":"PTRF/Cavin1 stabilizes cPLA2 by decreasing its proteasome-mediated degradation, resulting in increased cPLA2 activity and remodeled phospholipid composition in glioblastoma cells; this promotes tumor proliferation and suppresses CD8+ tumor-infiltrating lymphocytes.","method":"Co-immunoprecipitation, ubiquitination/proteasome inhibitor assays, nontargeted metabolomics, lipidomics, in vivo xenograft and intracranial tumor models","journal":"Neuro-oncology","confidence":"Medium","confidence_rationale":"Tier 2-3 — proteasome assay plus metabolomics with in vivo validation, single lab","pmids":["33140095"],"is_preprint":false},{"year":2024,"finding":"CAVIN1 controls hERG potassium channel dynamics at the cardiac plasma membrane; elevated CAVIN1 promotes sotalol-induced translocation of hERG from the plasma membrane to cytoskeleton-associated fractions, reducing IKr and prolonging repolarization; CAVIN1 knockdown abrogates this translocation and reduces susceptibility to drug-induced long QT.","method":"iPS-CM electrophysiology, siRNA knockdown, adenoviral CAVIN1 overexpression, cellular hERG distribution imaging, sotalol/E4031/vandetanib/clarithromycin treatments","journal":"Circulation","confidence":"High","confidence_rationale":"Tier 2 — reciprocal gain- and loss-of-function in patient-derived iPS-CMs with electrophysiological readout","pmids":["38682330"],"is_preprint":false},{"year":2024,"finding":"Cavin-1 competes with BMPR2 for binding to the scaffolding domain of Caveolin-1; hypoxia enhances the Cavin-1/CAV1 interaction while attenuating the CAV1/BMPR2 interaction and BMPR2 membrane localization; Cavin-1 reduces BMPR2 membrane localization and Smad signal transduction in pulmonary artery endothelial cells; Cavin-1 knockdown is resistant to CAV1-induced pulmonary hypertension in vivo.","method":"Co-immunoprecipitation of CAV1/Cavin-1/BMPR2 complexes, domain mapping, hypoxia experiments in PAECs, Cavin-1 knockdown in vivo pulmonary hypertension model","journal":"Communications biology","confidence":"High","confidence_rationale":"Tier 2 — reciprocal co-IP with domain mapping, plus in vivo epistasis confirmation","pmids":["38182755"],"is_preprint":false},{"year":2020,"finding":"Cavin-1 deficiency inhibits the RhoA-ROCK2-LIMK-Cofilin signaling pathway and suppresses cytoskeletal dynamics in liver sinusoidal endothelial cells, causing reduction of fenestrae and impaired liver permeability leading to defective hepatic glycogen metabolism and neonatal hypoglycemia; F-actin depolymerization with latrunculin A rescues fenestration defects.","method":"Cavin1 KO mice (C57BL/6J), electron microscopy, signaling pathway analysis, latrunculin A rescue experiment","journal":"Advanced science","confidence":"Medium","confidence_rationale":"Tier 2-3 — KO mouse with pathway analysis and pharmacological rescue, single lab","pmids":["33042738"],"is_preprint":false}],"current_model":"CAVIN1/PTRF is a multifunctional scaffolding protein that: (1) is essential for caveola biogenesis by forming a flexible polyhedral coat (via coiled-coil-mediated oligomerization and PI(4,5)P2-dependent membrane insertion) that stabilizes caveolin oligomers and prevents their lysosomal degradation; (2) in the nucleus promotes RNA Polymerase I transcript release and rDNA re-initiation by interacting with TTF-I, Pol I, and nascent pre-rRNA; (3) upon caveolar disassembly (triggered by mechanical, metabolic, or oxidative stimuli) translocates to the nucleus or cytosol to regulate NRF2 stability, focal adhesion remodeling via paxillin, and rRNA transcription; (4) interacts with SOCS3 to anchor cytokine-signaling inhibition at the plasma membrane; competes with BMPR2 for caveolin-1 scaffolding domain binding to modulate BMP/Smad signaling; docks MG53 at membrane injury sites for membrane repair; and controls hERG channel membrane dynamics in cardiomyocytes."},"narrative":{"teleology":[{"year":1998,"claim":"The molecular function of PTRF was established: it dissociates paused RNA Polymerase I ternary complexes by interacting with TTF-I, Pol I, and the 3′ end of nascent pre-rRNA, resolving how rDNA transcription termination is completed.","evidence":"In vitro transcription release assay with recombinant PTRF and RNA-binding mutants","pmids":["9582279"],"confidence":"High","gaps":["In vivo relevance of transcript release not yet shown","Structural basis of PTRF–Pol I interaction unknown","Post-translational regulation of this activity not addressed"]},{"year":1999,"claim":"The specificity of PTRF-mediated Pol I release was defined: PTRF acts only on termination-factor-paused complexes (TTF-I/Reb1p) and cannot release Pol I stalled by heterologous blocks, establishing it as a termination-coupled factor rather than a general release factor.","evidence":"In vitro transcription with immobilized templates and cross-species (mouse/yeast) termination factor comparison","pmids":["10589839"],"confidence":"High","gaps":["Whether PTRF is required for all Pol I termination events in vivo unknown","Mechanism of specificity (direct recognition of TTF-I vs. paused complex conformation) unresolved"]},{"year":2001,"claim":"PTRF was shown to facilitate Pol I reinitiation after transcript release, linking its activity to augmented rRNA synthesis rather than merely termination; phosphorylation was identified as a regulatory mechanism governing active vs. inactive PTRF pools.","evidence":"Multiple-round in vitro transcription in a PTRF-depleted reconstituted system with phosphorylation analysis","pmids":["11139612"],"confidence":"High","gaps":["Identity of kinases/phosphatases regulating PTRF unknown","Physiological stimuli controlling PTRF phosphorylation not identified"]},{"year":2004,"claim":"PTRF was unexpectedly identified as a major cytosolic coat protein of caveolae in adipocytes, revealing a second subcellular site of action; specific phosphorylation sites and calpain-cleavage sites were mapped, suggesting regulated proteolytic processing.","evidence":"Vectorial proteomics with nanospray-TOF MS on sealed caveolar vesicles from human adipocytes, confocal co-localization with caveolin","pmids":["15242332"],"confidence":"High","gaps":["Functional role of PTRF at caveolae not yet demonstrated","Significance of calpain cleavage for PTRF function unknown"]},{"year":2008,"claim":"CAVIN1 was established as essential and sufficient for caveola biogenesis: its loss abolishes caveolae in all tissues, causes caveolin mislocalization and lysosomal degradation (despite normal mRNA), and its re-expression rescues caveolae in caveola-deficient cells — fundamentally redefining caveola assembly as requiring a coat protein beyond caveolins alone.","evidence":"siRNA knockdown and ectopic expression in PC3 cells, FRAP, EM; global Cavin1 knockout mice with EM, immunoblotting, and qRT-PCR","pmids":["18191225","18840361"],"confidence":"High","gaps":["Molecular mechanism of caveolin stabilization by CAVIN1 unknown","Whether CAVIN1 directly contacts caveolins or acts indirectly unresolved","Stoichiometry of coat complex undetermined"]},{"year":2009,"claim":"Human loss-of-function PTRF mutations were shown to cause congenital generalized lipodystrophy with muscular dystrophy through secondary deficiency and mislocalization of all three caveolins, confirming the caveola-biogenesis role in human disease and establishing a direct disease link.","evidence":"Patient muscle biopsies, ectopic mutant PTRF expression in myoblasts, co-immunoprecipitation, rescue in patient fibroblasts with EM and AFM","pmids":["19726876","20300641"],"confidence":"High","gaps":["Genotype–phenotype correlation across different PTRF mutations incomplete","Relative contributions of caveolar vs. nuclear PTRF functions to lipodystrophy phenotype unclear"]},{"year":2011,"claim":"CAVIN1 was found to participate in diverse cellular processes beyond caveola structure — membrane repair (by docking MG53 at injury sites), cellular senescence (by sequestering Mdm2 at caveolae to activate p53/p21), and dynamic nuclear-to-cytoplasmic translocation during senescence — revealing it as a signaling hub whose function depends on subcellular redistribution.","evidence":"RNAi, mutant PTRF expression, live-cell membrane repair imaging, co-IP with MG53; overexpression/shRNA with EM, luciferase reporter, subcellular fractionation for senescence pathway","pmids":["21343302","21705337","21445100"],"confidence":"High","gaps":["How caveolar disassembly is sensed and triggers CAVIN1 release unknown","Direct mechanism of Mdm2 sequestration not structurally characterized","MG53–CAVIN1 interaction domain not mapped"]},{"year":2014,"claim":"The N-terminal leucine-zipper motif was identified as essential and sufficient for caveolae targeting, counteracting a central NLS, explaining the binary nuclear-vs-caveolar distribution; separately, CAVIN1's nuclear function in rRNA transcription was shown to be physiologically relevant in mature adipocytes responding to metabolic stress, providing a caveolae-independent explanation for lipodystrophy.","evidence":"Deletion mutant analysis with live-cell imaging and migration rescue; rDNA transcription assays in adipocytes with PTM mapping in PTRF-deficient mice","pmids":["25514038","27528195"],"confidence":"High","gaps":["Signals that regulate the leucine-zipper/NLS competition in vivo not identified","Which PTMs specifically control rDNA transcription function remain to be mapped to individual sites"]},{"year":2016,"claim":"The structural basis of the CAVIN1 coat was resolved: purified CAVIN1 forms 60S complexes that assemble into flexible polyhedral lattices on membranes; two coiled-coil domains mediate distinct oligomerization and membrane-binding steps, and caveolin 8S oligomers occupy the faces of the polyhedra.","evidence":"Electron cryotomography and in vitro reconstitution on liposomes with coiled-coil domain mutagenesis","pmids":["27834731"],"confidence":"High","gaps":["Atomic-resolution structure of the coat not available","How the coat accommodates different caveolar curvatures not explained","Stoichiometry of cavin1/cavin2/cavin3 subcomplexes in the coat unknown"]},{"year":2018,"claim":"CAVIN1 was shown to anchor SOCS3 at caveolae; the CAVIN1–SOCS3 interaction is essential for cAMP-induced inhibition of IL-6 signaling, establishing CAVIN1 as a platform for cytokine-signaling regulation at the plasma membrane.","evidence":"Reciprocal biochemical interaction, SOCS3 KO cells, confocal imaging, cytokine signaling assays in endothelial cells","pmids":["29330478"],"confidence":"High","gaps":["Whether CAVIN1 recruits other SOCS family members unknown","Structural basis of the SOCS3–CAVIN1 interface not determined"]},{"year":2022,"claim":"The membrane-insertion mechanism was resolved at the biophysical level: PI(4,5)P2-dependent adsorption of the trimeric HR1 domain is followed by partial helix separation and insertion, with flanking disordered regions enhancing kinetics and co-assembly with caveolin-1, providing a detailed model of how CAVIN1 senses membrane composition.","evidence":"Model membrane biophysics, liposome binding assays, computational modeling, mutagenesis validated in live cells","pmids":["35696574"],"confidence":"High","gaps":["How PI(4,5)P2 levels dynamically regulate caveola assembly/disassembly in vivo not shown","Whether other phosphoinositides modulate insertion unknown"]},{"year":2022,"claim":"A major signaling output of caveolar disassembly was identified: released cytoplasmic CAVIN1 directly binds NRF2 and promotes its degradation, maintaining cellular sensitivity to ferroptosis; this established a caveolae-to-oxidative-stress response signaling axis.","evidence":"Quantitative proteomics in CAVIN1 KO cells, reciprocal co-IP of CAVIN1–NRF2, live-cell caveolae imaging, zebrafish wound model","pmids":["36858041"],"confidence":"High","gaps":["Whether CAVIN1 promotes NRF2 degradation via KEAP1-dependent or -independent ubiquitination unknown","Relative contribution of this pathway versus caveolar mechanoprotection to tissue homeostasis not quantified"]},{"year":2024,"claim":"CAVIN1 was placed in two new physiological contexts: it controls hERG potassium channel membrane dynamics in cardiomyocytes (affecting drug-induced QT prolongation), and it competes with BMPR2 for caveolin-1's scaffolding domain to modulate BMP/Smad signaling and pulmonary hypertension, extending the competition model for caveolin-1 interactions.","evidence":"iPS-CM electrophysiology with reciprocal gain/loss-of-function for hERG; co-IP domain mapping, hypoxia experiments in PAECs, and in vivo epistasis in pulmonary hypertension model for BMPR2","pmids":["38682330","38182755"],"confidence":"High","gaps":["Whether CAVIN1-dependent hERG redistribution occurs via caveolar endocytosis or cytoskeletal sequestration is unresolved","How hypoxia increases CAVIN1–CAV1 interaction mechanistically is unknown","Therapeutic targetability of the CAVIN1–CAV1 competition not tested"]},{"year":null,"claim":"Major open questions remain: the atomic-resolution structure of the CAVIN1 coat and its dynamic remodeling under force; the precise signals and kinases that switch CAVIN1 between caveolar, cytosolic, and nuclear pools; whether CAVIN1's diverse cytosolic signaling partners (NRF2, paxillin, MG53, SOCS3) compete or are spatiotemporally segregated; and how caveolar versus nuclear CAVIN1 functions differentially contribute to human lipodystrophy and cardiometabolic disease.","evidence":"","pmids":[],"confidence":"Medium","gaps":["No atomic-resolution structure of CAVIN1 coat or its individual domains","Kinase(s) regulating nuclear–caveolar shuttling not identified","Relative pathogenic contributions of caveolar vs. rRNA transcription defects in CAVIN1-linked lipodystrophy unknown"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0003723","term_label":"RNA binding","supporting_discovery_ids":[0,1,25]},{"term_id":"GO:0005198","term_label":"structural molecule activity","supporting_discovery_ids":[4,5,19,26]},{"term_id":"GO:0060090","term_label":"molecular adaptor activity","supporting_discovery_ids":[10,17,23,32]},{"term_id":"GO:0008289","term_label":"lipid binding","supporting_discovery_ids":[19,24,26]},{"term_id":"GO:0098772","term_label":"molecular function regulator activity","supporting_discovery_ids":[11,27,31,32]}],"localization":[{"term_id":"GO:0005886","term_label":"plasma membrane","supporting_discovery_ids":[3,4,5,19,26]},{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[0,12,16,21,28]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[27,28]},{"term_id":"GO:0031410","term_label":"cytoplasmic vesicle","supporting_discovery_ids":[4,22]}],"pathway":[{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[0,1,2,16]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[11,17,27,32]},{"term_id":"R-HSA-8953854","term_label":"Metabolism of RNA","supporting_discovery_ids":[0,1,2,16]},{"term_id":"R-HSA-1852241","term_label":"Organelle biogenesis and maintenance","supporting_discovery_ids":[4,5,19,26]},{"term_id":"R-HSA-9612973","term_label":"Autophagy","supporting_discovery_ids":[22]},{"term_id":"R-HSA-5357801","term_label":"Programmed Cell Death","supporting_discovery_ids":[11,27]},{"term_id":"R-HSA-8953897","term_label":"Cellular responses to stimuli","supporting_discovery_ids":[27,28]}],"complexes":["Caveolar coat complex (cavin1/cavin2/cavin3 with caveolin oligomers)"],"partners":["CAV1","CAV2","CAV3","SOCS3","TRIM72","PXN","NFE2L2","BMPR2"],"other_free_text":[]},"mechanistic_narrative":"CAVIN1 (PTRF) is a multifunctional scaffolding protein essential for caveola biogenesis and ribosomal RNA transcription, with additional signaling roles that are dynamically regulated by its redistribution between the plasma membrane, cytosol, and nucleus. CAVIN1 forms flexible polyhedral coat lattices on membranes through coiled-coil-mediated oligomerization and PI(4,5)P2-dependent membrane insertion, stabilizing caveolin oligomers and preventing their lysosomal degradation; loss of CAVIN1 abolishes morphologically identifiable caveolae and reduces caveolin protein levels in all tissues examined [PMID:18191225, PMID:18840361, PMID:27834731, PMID:35696574]. In the nucleus, CAVIN1 dissociates paused RNA Polymerase I ternary complexes by interacting with TTF-I, Pol I, and nascent pre-rRNA, thereby promoting transcript release and rDNA reinitiation to augment ribosomal RNA synthesis [PMID:9582279, PMID:11139612, PMID:27528195]. Upon caveolar disassembly triggered by mechanical, metabolic, or oxidative stimuli, released CAVIN1 translocates to cytosol or nucleus where it facilitates NRF2 degradation to regulate ferroptosis susceptibility, remodels focal adhesions via paxillin interaction, competes with BMPR2 for caveolin-1 scaffolding domain binding to modulate BMP/Smad signaling, controls hERG channel membrane dynamics in cardiomyocytes, and anchors SOCS3 at caveolae to inhibit cytokine signaling [PMID:36858041, PMID:31126986, PMID:38182755, PMID:38682330, PMID:29330478]. Loss-of-function mutations in CAVIN1 cause a congenital generalized lipodystrophy with muscular dystrophy due to secondary deficiency and mislocalization of all three caveolin isoforms [PMID:19726876, PMID:20300641]."},"prefetch_data":{"uniprot":{"accession":"Q6NZI2","full_name":"Caveolae-associated protein 1","aliases":["Cavin-1","Polymerase I and transcript release factor"],"length_aa":390,"mass_kda":43.5,"function":"Plays an important role in caveolae formation and organization. Essential for the formation of caveolae in all tissues (PubMed:18056712, PubMed:18191225, PubMed:19726876). Core component of the CAVIN complex which is essential for recruitment of the complex to the caveolae in presence of calveolin-1 (CAV1). Essential for normal oligomerization of CAV1. Promotes ribosomal transcriptional activity in response to metabolic challenges in the adipocytes and plays an important role in the formation of the ribosomal transcriptional loop. Dissociates transcription complexes paused by DNA-bound TTF1, thereby releasing both RNA polymerase I and pre-RNA from the template (By similarity) (PubMed:18056712, PubMed:18191225, PubMed:19726876). The caveolae biogenesis pathway is required for the secretion of proteins such as GASK1A (By similarity)","subcellular_location":"Membrane, caveola; Cell membrane; Microsome; Endoplasmic reticulum; Cytoplasm, cytosol; Mitochondrion; Nucleus","url":"https://www.uniprot.org/uniprotkb/Q6NZI2/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/CAVIN1","classification":"Not Classified","n_dependent_lines":2,"n_total_lines":1208,"dependency_fraction":0.0016556291390728477},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/CAVIN1","total_profiled":1310},"omim":[{"mim_id":"620413","title":"GOLGI-ASSOCIATED KINASE 1A; GASK1A","url":"https://www.omim.org/entry/620413"},{"mim_id":"618303","title":"CAVEOLAE-ASSOCIATED PROTEIN 3; CAVIN3","url":"https://www.omim.org/entry/618303"},{"mim_id":"613327","title":"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 4; CGL4","url":"https://www.omim.org/entry/613327"},{"mim_id":"608594","title":"LIPODYSTROPHY, CONGENITAL GENERALIZED, TYPE 1; CGL1","url":"https://www.omim.org/entry/608594"},{"mim_id":"606513","title":"PROTEIN KINASE C AND CASEIN KINASE SUBSTRATE IN NEURONS 3; PACSIN3","url":"https://www.omim.org/entry/606513"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"Supported","locations":[{"location":"Plasma membrane","reliability":"Supported"},{"location":"Vesicles","reliability":"Additional"}],"tissue_specificity":"Low tissue specificity","tissue_distribution":"Detected in all","driving_tissues":[],"url":"https://www.proteinatlas.org/search/CAVIN1"},"hgnc":{"alias_symbol":["cavin-1","CGL4"],"prev_symbol":["PTRF"]},"alphafold":{"accession":"Q6NZI2","domains":[{"cath_id":"1.20.5","chopping":"45-120","consensus_level":"medium","plddt":96.6976,"start":45,"end":120},{"cath_id":"1.20.5","chopping":"217-300","consensus_level":"medium","plddt":72.9048,"start":217,"end":300}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6NZI2","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q6NZI2-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q6NZI2-F1-predicted_aligned_error_v6.png","plddt_mean":67.38},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=CAVIN1","jax_strain_url":"https://www.jax.org/strain/search?query=CAVIN1"},"sequence":{"accession":"Q6NZI2","fasta_url":"https://rest.uniprot.org/uniprotkb/Q6NZI2.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q6NZI2/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q6NZI2"}},"corpus_meta":[{"pmid":"18191225","id":"PMC_18191225","title":"PTRF-Cavin, a conserved cytoplasmic protein required for caveola formation and function.","date":"2008","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/18191225","citation_count":590,"is_preprint":false},{"pmid":"19726876","id":"PMC_19726876","title":"Human PTRF mutations cause secondary deficiency of caveolins resulting in muscular dystrophy with generalized lipodystrophy.","date":"2009","source":"The Journal of clinical investigation","url":"https://pubmed.ncbi.nlm.nih.gov/19726876","citation_count":302,"is_preprint":false},{"pmid":"18840361","id":"PMC_18840361","title":"Deletion of Cavin/PTRF causes global loss of caveolae, dyslipidemia, and glucose intolerance.","date":"2008","source":"Cell metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/18840361","citation_count":292,"is_preprint":false},{"pmid":"20300641","id":"PMC_20300641","title":"Fatal cardiac arrhythmia and long-QT syndrome in a new form of congenital generalized lipodystrophy with muscle rippling (CGL4) due to PTRF-CAVIN mutations.","date":"2010","source":"PLoS genetics","url":"https://pubmed.ncbi.nlm.nih.gov/20300641","citation_count":180,"is_preprint":false},{"pmid":"9582279","id":"PMC_9582279","title":"Cloning and functional characterization of PTRF, a novel protein which induces dissociation of paused ternary transcription complexes.","date":"1998","source":"The EMBO journal","url":"https://pubmed.ncbi.nlm.nih.gov/9582279","citation_count":128,"is_preprint":false},{"pmid":"15242332","id":"PMC_15242332","title":"Vectorial proteomics reveal targeting, phosphorylation and specific fragmentation of polymerase I and transcript release factor (PTRF) at the surface of caveolae in human adipocytes.","date":"2004","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/15242332","citation_count":124,"is_preprint":false},{"pmid":"29556340","id":"PMC_29556340","title":"The role of PTRF/Cavin1 as a biomarker in both glioma and serum exosomes.","date":"2018","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/29556340","citation_count":109,"is_preprint":false},{"pmid":"20684003","id":"PMC_20684003","title":"Congenital generalized lipodystrophy, type 4 (CGL4) associated with myopathy due to novel PTRF mutations.","date":"2010","source":"American journal of medical genetics. Part A","url":"https://pubmed.ncbi.nlm.nih.gov/20684003","citation_count":102,"is_preprint":false},{"pmid":"21343302","id":"PMC_21343302","title":"Polymerase transcriptase release factor (PTRF) anchors MG53 protein to cell injury site for initiation of membrane repair.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21343302","citation_count":91,"is_preprint":false},{"pmid":"25018864","id":"PMC_25018864","title":"Cavin-1/PTRF alters prostate cancer cell-derived extracellular vesicle content and internalization to attenuate extracellular vesicle-mediated osteoclastogenesis and osteoblast proliferation.","date":"2014","source":"Journal of extracellular vesicles","url":"https://pubmed.ncbi.nlm.nih.gov/25018864","citation_count":85,"is_preprint":false},{"pmid":"35547748","id":"PMC_35547748","title":"Neuronal STAT3/HIF-1α/PTRF axis-mediated bioenergetic disturbance exacerbates cerebral ischemia-reperfusion injury via PLA2G4A.","date":"2022","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/35547748","citation_count":82,"is_preprint":false},{"pmid":"27834731","id":"PMC_27834731","title":"Model for the architecture of caveolae based on a flexible, net-like assembly of Cavin1 and Caveolin discs.","date":"2016","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/27834731","citation_count":75,"is_preprint":false},{"pmid":"26725982","id":"PMC_26725982","title":"ROR1 sustains caveolae and survival signalling as a scaffold of cavin-1 and caveolin-1.","date":"2016","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/26725982","citation_count":75,"is_preprint":false},{"pmid":"31448673","id":"PMC_31448673","title":"CAV1-CAVIN1-LC3B-mediated autophagy regulates high glucose-stimulated LDL transcytosis.","date":"2019","source":"Autophagy","url":"https://pubmed.ncbi.nlm.nih.gov/31448673","citation_count":71,"is_preprint":false},{"pmid":"23934189","id":"PMC_23934189","title":"PTRF/cavin-1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer.","date":"2013","source":"Oncogene","url":"https://pubmed.ncbi.nlm.nih.gov/23934189","citation_count":65,"is_preprint":false},{"pmid":"22461895","id":"PMC_22461895","title":"PTRF/cavin-1 and MIF proteins are identified as non-small cell lung cancer biomarkers by label-free proteomics.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22461895","citation_count":65,"is_preprint":false},{"pmid":"20732728","id":"PMC_20732728","title":"PTRF-cavin-1 expression decreases the migration of PC3 prostate cancer cells: role of matrix metalloprotease 9.","date":"2010","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/20732728","citation_count":63,"is_preprint":false},{"pmid":"22030351","id":"PMC_22030351","title":"Expression of PTRF in PC-3 Cells modulates cholesterol dynamics and the actin cytoskeleton impacting secretion pathways.","date":"2011","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/22030351","citation_count":59,"is_preprint":false},{"pmid":"21445100","id":"PMC_21445100","title":"Regulation of cellular senescence by the essential caveolar component PTRF/Cavin-1.","date":"2011","source":"Cell research","url":"https://pubmed.ncbi.nlm.nih.gov/21445100","citation_count":58,"is_preprint":false},{"pmid":"10589839","id":"PMC_10589839","title":"Mechanism of transcription termination: PTRF interacts with the largest subunit of RNA polymerase I and dissociates paused transcription complexes from yeast and mouse.","date":"1999","source":"Molecular & general genetics : MGG","url":"https://pubmed.ncbi.nlm.nih.gov/10589839","citation_count":56,"is_preprint":false},{"pmid":"24509860","id":"PMC_24509860","title":"Pleiotropic effects of cavin-1 deficiency on lipid metabolism.","date":"2014","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/24509860","citation_count":55,"is_preprint":false},{"pmid":"33140095","id":"PMC_33140095","title":"PTRF/cavin-1 remodels phospholipid metabolism to promote tumor proliferation and suppress immune responses in glioblastoma by stabilizing cPLA2.","date":"2021","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/33140095","citation_count":53,"is_preprint":false},{"pmid":"23941874","id":"PMC_23941874","title":"Caveolin-1/PTRF upregulation constitutes a mechanism for mediating p53-induced cellular senescence: implications for evidence-based therapy of delayed wound healing in diabetes.","date":"2013","source":"American journal of physiology. Endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/23941874","citation_count":52,"is_preprint":false},{"pmid":"22912783","id":"PMC_22912783","title":"Co-regulation of cell polarization and migration by caveolar proteins PTRF/Cavin-1 and caveolin-1.","date":"2012","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/22912783","citation_count":52,"is_preprint":false},{"pmid":"20564315","id":"PMC_20564315","title":"Changes in caveolae, caveolin, and polymerase 1 and transcript release factor (PTRF) expression in prostate cancer progression.","date":"2010","source":"The Prostate","url":"https://pubmed.ncbi.nlm.nih.gov/20564315","citation_count":52,"is_preprint":false},{"pmid":"20638880","id":"PMC_20638880","title":"A Japanese child with asymptomatic elevation of serum creatine kinase shows PTRF-CAVIN mutation matching with congenital generalized lipodystrophy type 4.","date":"2010","source":"Molecular genetics and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/20638880","citation_count":51,"is_preprint":false},{"pmid":"33496726","id":"PMC_33496726","title":"Caveolin-1 and cavin1 act synergistically to generate a unique lipid environment in caveolae.","date":"2021","source":"The Journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/33496726","citation_count":50,"is_preprint":false},{"pmid":"23938946","id":"PMC_23938946","title":"Caveola-forming proteins caveolin-1 and PTRF in prostate cancer.","date":"2013","source":"Nature reviews. Urology","url":"https://pubmed.ncbi.nlm.nih.gov/23938946","citation_count":49,"is_preprint":false},{"pmid":"10727401","id":"PMC_10727401","title":"PTRF (polymerase I and transcript-release factor) is tissue-specific and interacts with the BFCOL1 (binding factor of a type-I collagen promoter) zinc-finger transcription factor which binds to the two mouse type-I collagen gene promoters.","date":"2000","source":"The Biochemical journal","url":"https://pubmed.ncbi.nlm.nih.gov/10727401","citation_count":49,"is_preprint":false},{"pmid":"23214712","id":"PMC_23214712","title":"PTRF/cavin-1 is essential for multidrug resistance in cancer cells.","date":"2013","source":"Journal of proteome research","url":"https://pubmed.ncbi.nlm.nih.gov/23214712","citation_count":47,"is_preprint":false},{"pmid":"11139612","id":"PMC_11139612","title":"The transcript release factor PTRF augments ribosomal gene transcription by facilitating reinitiation of RNA polymerase I.","date":"2001","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/11139612","citation_count":46,"is_preprint":false},{"pmid":"25588833","id":"PMC_25588833","title":"Cavin3 interacts with cavin1 and caveolin1 to increase surface dynamics of caveolae.","date":"2015","source":"Journal of cell science","url":"https://pubmed.ncbi.nlm.nih.gov/25588833","citation_count":45,"is_preprint":false},{"pmid":"27528195","id":"PMC_27528195","title":"PTRF/Cavin-1 promotes efficient ribosomal RNA transcription in response to metabolic challenges.","date":"2016","source":"eLife","url":"https://pubmed.ncbi.nlm.nih.gov/27528195","citation_count":44,"is_preprint":false},{"pmid":"21705337","id":"PMC_21705337","title":"Polymerase I and transcript release factor (PTRF)/cavin-1 is a novel regulator of stress-induced premature senescence.","date":"2011","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/21705337","citation_count":43,"is_preprint":false},{"pmid":"24024685","id":"PMC_24024685","title":"Novel PTRF mutation in a child with mild myopathy and very mild congenital lipodystrophy.","date":"2013","source":"BMC medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/24024685","citation_count":42,"is_preprint":false},{"pmid":"21152401","id":"PMC_21152401","title":"IGF-IR internalizes with Caveolin-1 and PTRF/Cavin in HaCat cells.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21152401","citation_count":40,"is_preprint":false},{"pmid":"24123650","id":"PMC_24123650","title":"PTRF/Cavin-1 decreases prostate cancer angiogenesis and lymphangiogenesis.","date":"2013","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/24123650","citation_count":39,"is_preprint":false},{"pmid":"20585024","id":"PMC_20585024","title":"Quantitative proteomics of caveolin-1-regulated proteins: characterization of polymerase i and transcript release factor/CAVIN-1 IN endothelial cells.","date":"2010","source":"Molecular & cellular proteomics : MCP","url":"https://pubmed.ncbi.nlm.nih.gov/20585024","citation_count":38,"is_preprint":false},{"pmid":"25822667","id":"PMC_25822667","title":"Cavin-1 and Caveolin-1 are both required to support cell proliferation, migration and anchorage-independent cell growth in rhabdomyosarcoma.","date":"2015","source":"Laboratory investigation; a journal of technical methods and pathology","url":"https://pubmed.ncbi.nlm.nih.gov/25822667","citation_count":33,"is_preprint":false},{"pmid":"35673568","id":"PMC_35673568","title":"PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastoma.","date":"2022","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/35673568","citation_count":32,"is_preprint":false},{"pmid":"25721873","id":"PMC_25721873","title":"Novel nonsense mutation in the PTRF gene underlies congenital generalized lipodystrophy in a consanguineous Saudi family.","date":"2015","source":"European journal of medical genetics","url":"https://pubmed.ncbi.nlm.nih.gov/25721873","citation_count":31,"is_preprint":false},{"pmid":"35069587","id":"PMC_35069587","title":"PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in Glioblastoma.","date":"2022","source":"Frontiers in immunology","url":"https://pubmed.ncbi.nlm.nih.gov/35069587","citation_count":31,"is_preprint":false},{"pmid":"31605605","id":"PMC_31605605","title":"PTRF/CAVIN1, regulated by SHC1 through the EGFR pathway, is found in urine exosomes as a potential biomarker of ccRCC.","date":"2020","source":"Carcinogenesis","url":"https://pubmed.ncbi.nlm.nih.gov/31605605","citation_count":30,"is_preprint":false},{"pmid":"27612189","id":"PMC_27612189","title":"PTRF/Cavin-1 Deficiency Causes Cardiac Dysfunction Accompanied by Cardiomyocyte Hypertrophy and Cardiac Fibrosis.","date":"2016","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/27612189","citation_count":29,"is_preprint":false},{"pmid":"25521582","id":"PMC_25521582","title":"Hypoxia inhibits Cavin-1 and Cavin-2 expression and down-regulates caveolae in adipocytes.","date":"2014","source":"Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/25521582","citation_count":29,"is_preprint":false},{"pmid":"25942420","id":"PMC_25942420","title":"Galectin-3 Overrides PTRF/Cavin-1 Reduction of PC3 Prostate Cancer Cell Migration.","date":"2015","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/25942420","citation_count":28,"is_preprint":false},{"pmid":"20427576","id":"PMC_20427576","title":"Caveolin-1 induces formation of membrane tubules that sense actomyosin tension and are inhibited by polymerase I and transcript release factor/cavin-1.","date":"2010","source":"Molecular biology of the cell","url":"https://pubmed.ncbi.nlm.nih.gov/20427576","citation_count":28,"is_preprint":false},{"pmid":"36858041","id":"PMC_36858041","title":"Caveolae sense oxidative stress through membrane lipid peroxidation and cytosolic release of CAVIN1 to regulate NRF2.","date":"2023","source":"Developmental cell","url":"https://pubmed.ncbi.nlm.nih.gov/36858041","citation_count":27,"is_preprint":false},{"pmid":"29330478","id":"PMC_29330478","title":"Interaction of suppressor of cytokine signalling 3 with cavin-1 links SOCS3 function and cavin-1 stability.","date":"2018","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/29330478","citation_count":27,"is_preprint":false},{"pmid":"24658465","id":"PMC_24658465","title":"Arterial dysfunction but maintained systemic blood pressure in cavin-1-deficient mice.","date":"2014","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/24658465","citation_count":26,"is_preprint":false},{"pmid":"28337292","id":"PMC_28337292","title":"MiR-217 promotes cutaneous squamous cell carcinoma progression by targeting PTRF.","date":"2017","source":"American journal of translational research","url":"https://pubmed.ncbi.nlm.nih.gov/28337292","citation_count":26,"is_preprint":false},{"pmid":"18191216","id":"PMC_18191216","title":"PTRF triggers a cave in.","date":"2008","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/18191216","citation_count":26,"is_preprint":false},{"pmid":"24303100","id":"PMC_24303100","title":"Elevated pulmonary arterial pressure and altered expression of Ddah1 and Arg1 in mice lacking cavin-1/PTRF.","date":"2013","source":"Physiological reports","url":"https://pubmed.ncbi.nlm.nih.gov/24303100","citation_count":26,"is_preprint":false},{"pmid":"24812087","id":"PMC_24812087","title":"Polymerase I and transcript release factor (PTRF) regulates adipocyte differentiation and determines adipose tissue expandability.","date":"2014","source":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","url":"https://pubmed.ncbi.nlm.nih.gov/24812087","citation_count":25,"is_preprint":false},{"pmid":"27894957","id":"PMC_27894957","title":"DNA methylation profiling identifies PTRF/Cavin-1 as a novel tumor suppressor in Ewing sarcoma when co-expressed with caveolin-1.","date":"2016","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/27894957","citation_count":25,"is_preprint":false},{"pmid":"23634221","id":"PMC_23634221","title":"Cavin1; a regulator of lung function and macrophage phenotype.","date":"2013","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/23634221","citation_count":24,"is_preprint":false},{"pmid":"31922193","id":"PMC_31922193","title":"Lessons from cavin-1 deficiency.","date":"2020","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/31922193","citation_count":23,"is_preprint":false},{"pmid":"24646232","id":"PMC_24646232","title":"Cavin-1: caveolae-dependent signalling and cardiovascular disease.","date":"2014","source":"Biochemical Society transactions","url":"https://pubmed.ncbi.nlm.nih.gov/24646232","citation_count":23,"is_preprint":false},{"pmid":"22643325","id":"PMC_22643325","title":"Impaired contractility and detrusor hypertrophy in cavin-1-deficient mice.","date":"2012","source":"European journal of pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/22643325","citation_count":23,"is_preprint":false},{"pmid":"29262615","id":"PMC_29262615","title":"Cavin-1 regulates caveolae-mediated LDL transcytosis: crosstalk in an AMPK/eNOS/ NF-κB/Sp1 loop.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/29262615","citation_count":22,"is_preprint":false},{"pmid":"28393200","id":"PMC_28393200","title":"MicroRNA-187 modulates epithelial-mesenchymal transition by targeting PTRF in non-small cell lung cancer.","date":"2017","source":"Oncology reports","url":"https://pubmed.ncbi.nlm.nih.gov/28393200","citation_count":21,"is_preprint":false},{"pmid":"25107607","id":"PMC_25107607","title":"Emerging role of polymerase-1 and transcript release factor (PTRF/ Cavin-1) in health and disease.","date":"2014","source":"Cell and tissue research","url":"https://pubmed.ncbi.nlm.nih.gov/25107607","citation_count":21,"is_preprint":false},{"pmid":"37346294","id":"PMC_37346294","title":"Non-alcoholic fatty liver disease combined with rheumatoid arthritis exacerbates liver fibrosis by stimulating co-localization of PTRF and TLR4 in rats.","date":"2023","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/37346294","citation_count":21,"is_preprint":false},{"pmid":"37454215","id":"PMC_37454215","title":"PTRF-IL33-ZBP1 signaling mediating macrophage necroptosis contributes to HDM-induced airway inflammation.","date":"2023","source":"Cell death & disease","url":"https://pubmed.ncbi.nlm.nih.gov/37454215","citation_count":20,"is_preprint":false},{"pmid":"28529892","id":"PMC_28529892","title":"Caveolae, caveolin-1 and cavin-1: Emerging roles in pulmonary hypertension.","date":"2015","source":"World journal of respirology","url":"https://pubmed.ncbi.nlm.nih.gov/28529892","citation_count":20,"is_preprint":false},{"pmid":"38092144","id":"PMC_38092144","title":"Neovascularization directed by CAVIN1/CCBE1/VEGFC confers TMZ-resistance in glioblastoma.","date":"2023","source":"Cancer letters","url":"https://pubmed.ncbi.nlm.nih.gov/38092144","citation_count":18,"is_preprint":false},{"pmid":"30949900","id":"PMC_30949900","title":"Correlation of the invasive potential of glioblastoma and expression of caveola-forming proteins caveolin-1 and CAVIN1.","date":"2019","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/30949900","citation_count":18,"is_preprint":false},{"pmid":"36443833","id":"PMC_36443833","title":"UBE2O ubiquitinates PTRF/CAVIN1 and inhibits the secretion of exosome-related PTRF/CAVIN1.","date":"2022","source":"Cell communication and signaling : CCS","url":"https://pubmed.ncbi.nlm.nih.gov/36443833","citation_count":17,"is_preprint":false},{"pmid":"35696574","id":"PMC_35696574","title":"Membrane insertion mechanism of the caveola coat protein Cavin1.","date":"2022","source":"Proceedings of the National Academy of Sciences of the United States of America","url":"https://pubmed.ncbi.nlm.nih.gov/35696574","citation_count":16,"is_preprint":false},{"pmid":"30476128","id":"PMC_30476128","title":"Postmortem Findings in a Young Man With Congenital Generalized Lipodystrophy, Type 4 Due to CAVIN1 Mutations.","date":"2019","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/30476128","citation_count":16,"is_preprint":false},{"pmid":"27856429","id":"PMC_27856429","title":"Knockdown of PTRF ameliorates adipocyte differentiation and functionality of human mesenchymal stem cells.","date":"2016","source":"American journal of physiology. Cell physiology","url":"https://pubmed.ncbi.nlm.nih.gov/27856429","citation_count":16,"is_preprint":false},{"pmid":"28343262","id":"PMC_28343262","title":"Cavin-1 deficiency modifies myocardial and coronary function, stretch responses and ischaemic tolerance: roles of NOS over-activity.","date":"2017","source":"Basic research in cardiology","url":"https://pubmed.ncbi.nlm.nih.gov/28343262","citation_count":16,"is_preprint":false},{"pmid":"28289716","id":"PMC_28289716","title":"Muscular dystrophy in PTFR/cavin-1 null mice.","date":"2017","source":"JCI insight","url":"https://pubmed.ncbi.nlm.nih.gov/28289716","citation_count":15,"is_preprint":false},{"pmid":"32550897","id":"PMC_32550897","title":"Homotrimer cavin1 interacts with caveolin1 to facilitate tumor growth and activate microglia through extracellular vesicles in glioma.","date":"2020","source":"Theranostics","url":"https://pubmed.ncbi.nlm.nih.gov/32550897","citation_count":15,"is_preprint":false},{"pmid":"37501786","id":"PMC_37501786","title":"A new mutation in the CAVIN1/PTRF gene in two siblings with congenital generalized lipodystrophy type 4: case reports and review of the literature.","date":"2023","source":"Frontiers in endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/37501786","citation_count":15,"is_preprint":false},{"pmid":"27203393","id":"PMC_27203393","title":"PTRF suppresses the progression of colorectal cancers.","date":"2017","source":"Oncotarget","url":"https://pubmed.ncbi.nlm.nih.gov/27203393","citation_count":15,"is_preprint":false},{"pmid":"27168348","id":"PMC_27168348","title":"Caveolin-1, Caveolin-2 and Cavin-1 are strong predictors of adipogenic differentiation in human tumors and cell lines of liposarcoma.","date":"2016","source":"European journal of cell biology","url":"https://pubmed.ncbi.nlm.nih.gov/27168348","citation_count":15,"is_preprint":false},{"pmid":"27144934","id":"PMC_27144934","title":"Maladaptative Autophagy Impairs Adipose Function in Congenital Generalized Lipodystrophy due to Cavin-1 Deficiency.","date":"2016","source":"The Journal of clinical endocrinology and metabolism","url":"https://pubmed.ncbi.nlm.nih.gov/27144934","citation_count":14,"is_preprint":false},{"pmid":"36935311","id":"PMC_36935311","title":"Serum amyloid A and interleukin -1β facilitate LDL transcytosis across endothelial cells and atherosclerosis via NF-κB/caveolin-1/cavin-1 pathway.","date":"2023","source":"Atherosclerosis","url":"https://pubmed.ncbi.nlm.nih.gov/36935311","citation_count":13,"is_preprint":false},{"pmid":"24471649","id":"PMC_24471649","title":"Increased polymerase I and transcript release factor (Cavin-1) expression attenuates platelet-derived growth factor receptor signalling in senescent human fibroblasts.","date":"2014","source":"Clinical and experimental pharmacology & physiology","url":"https://pubmed.ncbi.nlm.nih.gov/24471649","citation_count":12,"is_preprint":false},{"pmid":"30745727","id":"PMC_30745727","title":"Metreleptin treatment for congenital generalized lipodystrophy type 4 (CGL4): a case report.","date":"2019","source":"Clinical pediatric endocrinology : case reports and clinical investigations : official journal of the Japanese Society for Pediatric Endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/30745727","citation_count":11,"is_preprint":false},{"pmid":"21683594","id":"PMC_21683594","title":"A study of FHL1, BAG3, MATR3, PTRF and TCAP in Australian muscular dystrophy patients.","date":"2011","source":"Neuromuscular disorders : NMD","url":"https://pubmed.ncbi.nlm.nih.gov/21683594","citation_count":11,"is_preprint":false},{"pmid":"25514038","id":"PMC_25514038","title":"The N-terminal leucine-zipper motif in PTRF/cavin-1 is essential and sufficient for its caveolae-association.","date":"2014","source":"Biochemical and biophysical research communications","url":"https://pubmed.ncbi.nlm.nih.gov/25514038","citation_count":11,"is_preprint":false},{"pmid":"32065471","id":"PMC_32065471","title":"A role for caveola-forming proteins caveolin-1 and CAVIN1 in the pro-invasive response of glioblastoma to osmotic and hydrostatic pressure.","date":"2020","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/32065471","citation_count":11,"is_preprint":false},{"pmid":"37651725","id":"PMC_37651725","title":"EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastoma.","date":"2024","source":"Neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/37651725","citation_count":10,"is_preprint":false},{"pmid":"28751541","id":"PMC_28751541","title":"Downregulation of Cavin-1 Expression via Increasing Caveolin-1 Degradation Prompts the Proliferation and Migration of Vascular Smooth Muscle Cells in Balloon Injury-Induced Neointimal Hyperplasia.","date":"2017","source":"Journal of the American Heart Association","url":"https://pubmed.ncbi.nlm.nih.gov/28751541","citation_count":10,"is_preprint":false},{"pmid":"35275225","id":"PMC_35275225","title":"Cavin-1 promotes M2 macrophages/microglia polarization via SOCS3.","date":"2022","source":"Inflammation research : official journal of the European Histamine Research Society ... [et al.]","url":"https://pubmed.ncbi.nlm.nih.gov/35275225","citation_count":9,"is_preprint":false},{"pmid":"34690766","id":"PMC_34690766","title":"Suppression of PTRF Alleviates Post-Infectious Irritable Bowel Syndrome via Downregulation of the TLR4 Pathway in Rats.","date":"2021","source":"Frontiers in pharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/34690766","citation_count":9,"is_preprint":false},{"pmid":"38182755","id":"PMC_38182755","title":"The Cavin-1/Caveolin-1 interaction attenuates BMP/Smad signaling in pulmonary hypertension by interfering with BMPR2/Caveolin-1 binding.","date":"2024","source":"Communications biology","url":"https://pubmed.ncbi.nlm.nih.gov/38182755","citation_count":9,"is_preprint":false},{"pmid":"31126986","id":"PMC_31126986","title":"Cavin-1/PTRF mediates insulin-dependent focal adhesion remodeling and ameliorates high-fat diet-induced inflammatory responses in mice.","date":"2019","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/31126986","citation_count":9,"is_preprint":false},{"pmid":"31862213","id":"PMC_31862213","title":"PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomy.","date":"2019","source":"Urologic oncology","url":"https://pubmed.ncbi.nlm.nih.gov/31862213","citation_count":8,"is_preprint":false},{"pmid":"33042738","id":"PMC_33042738","title":"Cavin1 Deficiency Causes Disorder of Hepatic Glycogen Metabolism and Neonatal Death by Impacting Fenestrations in Liver Sinusoidal Endothelial Cells.","date":"2020","source":"Advanced science (Weinheim, Baden-Wurttemberg, Germany)","url":"https://pubmed.ncbi.nlm.nih.gov/33042738","citation_count":8,"is_preprint":false},{"pmid":"37774837","id":"PMC_37774837","title":"Cavin1 activates the Wnt/β-catenin pathway to influence the proliferation and migration of hepatocellular carcinoma.","date":"2023","source":"Annals of hepatology","url":"https://pubmed.ncbi.nlm.nih.gov/37774837","citation_count":7,"is_preprint":false},{"pmid":"36608443","id":"PMC_36608443","title":"Defected lipid rafts suppress cavin1-dependent IFN-α signaling endosome in paroxysmal nocturnal hemoglobinuria.","date":"2023","source":"International immunopharmacology","url":"https://pubmed.ncbi.nlm.nih.gov/36608443","citation_count":7,"is_preprint":false},{"pmid":"33755319","id":"PMC_33755319","title":"Deficiency of cold-inducible RNA-binding protein exacerbated monocrotaline-induced pulmonary artery hypertension through Caveolin1 and CAVIN1.","date":"2021","source":"Journal of cellular and molecular medicine","url":"https://pubmed.ncbi.nlm.nih.gov/33755319","citation_count":7,"is_preprint":false},{"pmid":"32467771","id":"PMC_32467771","title":"Unusual clinical features associated with congenital generalized lipodystrophy type 4 in a patient with a novel E211X CAVIN1 gene variant.","date":"2020","source":"Clinical diabetes and endocrinology","url":"https://pubmed.ncbi.nlm.nih.gov/32467771","citation_count":7,"is_preprint":false},{"pmid":"35513070","id":"PMC_35513070","title":"Deformation of caveolae impacts global transcription and translation processes through relocalization of cavin-1.","date":"2022","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/35513070","citation_count":6,"is_preprint":false},{"pmid":"29381831","id":"PMC_29381831","title":"Ptrf transgenic mice exhibit obesity and fatty liver.","date":"2018","source":"Clinical and experimental pharmacology & physiology","url":"https://pubmed.ncbi.nlm.nih.gov/29381831","citation_count":5,"is_preprint":false},{"pmid":"38682330","id":"PMC_38682330","title":"CAVIN1-Mediated hERG Dynamics: A Novel Mechanism Underlying the Interindividual Variability in Drug-Induced Long QT.","date":"2024","source":"Circulation","url":"https://pubmed.ncbi.nlm.nih.gov/38682330","citation_count":4,"is_preprint":false},{"pmid":"35405042","id":"PMC_35405042","title":"Congenital generalized lipodystrophy type 4 due to a novel PTRF/CAVIN1 pathogenic variant in a child: effects of metreleptin substitution.","date":"2022","source":"Journal of pediatric endocrinology & metabolism : JPEM","url":"https://pubmed.ncbi.nlm.nih.gov/35405042","citation_count":4,"is_preprint":false}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":51807,"output_tokens":7847,"usd":0.136563},"stage2":{"model":"claude-opus-4-6","input_tokens":11606,"output_tokens":4265,"usd":0.246982},"total_usd":0.383545,"stage1_batch_id":"msgbatch_011kfMfE81o6CTcyhVUqumuW","stage2_batch_id":"msgbatch_01DTputS6WNkH745x1nVSoBo","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 1998,\n      \"finding\": \"PTRF (Cavin1) was cloned and shown to dissociate paused RNA Polymerase I ternary transcription complexes in vitro by releasing both nascent pre-rRNA transcripts and Pol I from the template; it interacts with TTF-I, Pol I, and the 3' end of pre-rRNA, with 3'-terminal uridylates essential for binding and release activity.\",\n      \"method\": \"In vitro transcription release assay with recombinant PTRF, protein–protein interaction studies, RNA-binding assay with 3'-end mutants\",\n      \"journal\": \"The EMBO journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstituted in vitro activity with mutagenesis validation\",\n      \"pmids\": [\"9582279\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 1999,\n      \"finding\": \"PTRF interacts with the largest subunit of RNA Polymerase I and promotes dissociation of paused ternary transcription complexes through conserved interactions with Pol I and the termination factors TTF-I/Reb1p, but cannot release Pol I stalled by a non-termination factor (lac repressor), establishing specificity for termination-factor-dependent pausing.\",\n      \"method\": \"In vitro transcription termination assay using immobilized tailed templates from yeast and mouse; protein–protein interaction studies\",\n      \"journal\": \"Molecular & general genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with cross-species validation\",\n      \"pmids\": [\"10589839\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2001,\n      \"finding\": \"PTRF-mediated transcript release facilitates reinitiation of RNA Polymerase I transcription, thereby augmenting ribosomal RNA synthesis; PTRF is phosphorylated at multiple sites and fractionates into transcriptionally active and inactive forms, suggesting phosphorylation regulates its activity.\",\n      \"method\": \"Multiple-round and single-round in vitro transcription assays; reconstituted PTRF-free transcription system; phosphorylation analysis\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution in PTRF-free system with multiple orthogonal assays\",\n      \"pmids\": [\"11139612\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2004,\n      \"finding\": \"PTRF is a major protein at the cytosolic surface of caveolae in human adipocytes, is phosphorylated at Ser-36, Ser-40, Ser-365, and Ser-366, and is subject to calpain-mediated cleavage at two sites within PEST domains, producing multiple truncated forms; co-localization with caveolin confirmed by immunofluorescence.\",\n      \"method\": \"Vectorial proteomics (differential proteolysis + MS on sealed caveolar vesicles), nanospray-quadrupole-TOF MS, immunofluorescence confocal microscopy\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — multiple orthogonal methods including MS-based phosphosite mapping on native protein\",\n      \"pmids\": [\"15242332\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"PTRF/Cavin1 is required for caveola formation and for sequestration of caveolin into immobile caveolae at the plasma membrane; without PTRF, caveolin resides on flat plasma membrane with increased lateral mobility and undergoes accelerated lysosomal degradation; expression of PTRF in caveolae-deficient PC3 cells is sufficient to induce caveola formation.\",\n      \"method\": \"Comparative proteomics, siRNA knockdown, ectopic expression in PC3 cells, zebrafish knockdown, FRAP, electron microscopy, live imaging\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods, in vitro and in vivo rescue, replicated in two model systems\",\n      \"pmids\": [\"18191225\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2008,\n      \"finding\": \"Global deletion of Cavin1 in mice abolishes morphologically detectable caveolae in all cell types and markedly reduces protein expression of all three caveolin isoforms (while caveolin mRNA remains normal or elevated), demonstrating Cavin1 is essential for caveolae formation and post-translational stabilization of caveolins.\",\n      \"method\": \"Targeted gene disruption in mice, electron microscopy, immunoblotting, qRT-PCR\",\n      \"journal\": \"Cell metabolism\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — clean knockout mouse with multiple phenotypic readouts and molecular mechanism\",\n      \"pmids\": [\"18840361\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2009,\n      \"finding\": \"Human PTRF mutations cause secondary deficiency and mislocalization of all three caveolin family members; disease-associated mutations cause PTRF mislocalization and disrupt its physical interaction with caveolins, confirming PTRF is required for caveolae formation and proper caveolin localization in human cells.\",\n      \"method\": \"Patient muscle biopsy analysis, ectopic expression of mutant PTRF constructs in myoblasts, co-immunoprecipitation, immunofluorescence\",\n      \"journal\": \"The Journal of clinical investigation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — human genetics plus functional validation with reciprocal interaction and localization studies\",\n      \"pmids\": [\"19726876\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"In patient fibroblasts lacking PTRF, caveolin-1 fails to localize to the cell surface and caveolae are reduced to <3%; transfection of full-length PTRF re-establishes caveolae, confirming the essential and sufficient role of PTRF in caveola biogenesis.\",\n      \"method\": \"Patient fibroblast analysis, electron microscopy, Atomic Force Microscopy, transfection rescue\",\n      \"journal\": \"PLoS genetics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — rescue experiment with multiple imaging modalities in human patient cells\",\n      \"pmids\": [\"20300641\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PTRF/Cavin1 expression in PC3 prostate cancer cells reduces cell migration via decreased MMP9 production, and this effect is independent of caveola formation.\",\n      \"method\": \"Ectopic expression of PTRF in PC3 cells, cell migration assays, MMP9 ELISA/zymography\",\n      \"journal\": \"European journal of cell biology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — loss-of-function/gain-of-function with defined molecular readout; caveola-independence demonstrated by comparison\",\n      \"pmids\": [\"20732728\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"PTRF/Cavin1 interacts with the BFCOL1 zinc-finger transcription factor and enhances its binding to the mouse proalpha2(I) collagen proximal promoter in vitro, while suppressing promoter activity in transient transfection assays, indicating a role for PTRF in RNA Pol II transcription regulation.\",\n      \"method\": \"Yeast two-hybrid screening, in vitro EMSA, transient transfection reporter assay\",\n      \"journal\": \"The Biochemical journal\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — two orthogonal methods (interaction + functional assay) in a single study\",\n      \"pmids\": [\"10727401\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PTRF acts as a docking protein for MG53 at plasma membrane injury sites, potentially by binding exposed membrane cholesterol; cells lacking PTRF show defective MG53 trafficking to injury sites, and a disease-associated PTRF mutation causes aberrant nuclear localization of PTRF and disrupts MG53-mediated membrane resealing; overexpression of PTRF rescues membrane repair defects in dystrophic muscle.\",\n      \"method\": \"RNAi knockdown, ectopic expression with mutant PTRF, live imaging of membrane repair, co-immunoprecipitation, fluorescence microscopy\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods including KD, mutant expression, live-cell imaging, and rescue\",\n      \"pmids\": [\"21343302\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PTRF/Cavin1 expression is increased in senescent fibroblasts; PTRF overexpression induces cellular senescence via sequestration of Mdm2 into caveolar membranes away from p53, activating the p53/p21 pathway; a caveola-membrane-targeting-deficient PTRF mutant fails to activate p53 or senescence, and PTRF translocates from nucleus to cytosol/plasma membrane during senescence.\",\n      \"method\": \"Overexpression and shRNA knockdown, immunofluorescence, electron microscopy, luciferase reporter assay, subcellular fractionation, mutant PTRF expression\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods with mechanistic mutant validation\",\n      \"pmids\": [\"21705337\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PTRF/Cavin1 localizes to nuclei of young/quiescent fibroblasts and translocates to cytosol and plasma membrane during cellular senescence; the role of PTRF in senescence is dependent on its targeting to caveolae and interaction with caveolin-1, regulated by PTRF phosphorylation.\",\n      \"method\": \"Immunofluorescence, electron microscopy, overexpression/knockdown, phosphorylation analysis\",\n      \"journal\": \"Cell research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — localization with functional link, but interaction with caveolin-1 not fully validated by co-IP\",\n      \"pmids\": [\"21445100\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2011,\n      \"finding\": \"PTRF expression modulates cholesterol distribution and impairs recruitment of actin cytoskeletal proteins to detergent-resistant membranes, leading to reduced prostasome secretion and decreased secretion of a subset of proteins including proteases, cytokines, and growth regulatory proteins.\",\n      \"method\": \"SILAC quantitative proteomics, subcellular fractionation, detergent-resistant membrane isolation, cholesterol modulation\",\n      \"journal\": \"Molecular & cellular proteomics\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 — quantitative proteomics with biochemical fractionation, single lab\",\n      \"pmids\": [\"22030351\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"PTRF/Cavin1 co-regulates cell polarization and migration with caveolin-1; PTRF modulates subcellular localization of Rac1, caveolin-1, and PKCα caveola recruitment in migrating cells; PTRF quantitatively reduces cell migration and induces mesenchymal-to-epithelial reversion, with caveola-independent functions identified.\",\n      \"method\": \"Fluorescence imaging, quantitative proteomics, cell migration assays, selective manipulation of PTRF and caveolin-1 expression in multiple cell systems\",\n      \"journal\": \"PloS one\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple cell systems and orthogonal methods, single lab\",\n      \"pmids\": [\"22912783\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"PTRF/Cavin1 neutralizes non-caveolar caveolin-1 microdomains in prostate cancer; cavin-1 co-expression reverses the oncogenic effects of caveolin-1 in caveolin-1-positive cells; absence of cavin-1 in advanced prostate cancer allows caveolin-1 to reside outside caveolae in tumor-promoting microdomains; cavin-1 reduces IL-6 microenvironmental function.\",\n      \"method\": \"Tissue microarray, ectopic expression in PC3/LNCaP/22Rv1 cells, anchorage-independent growth assays, orthotopic xenograft mouse model\",\n      \"journal\": \"Oncogene\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — in vitro and in vivo functional assays with mechanistic pathway placement\",\n      \"pmids\": [\"23934189\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"PTRF/Cavin1 promotes efficient rRNA transcription in response to metabolic challenges in mature adipocytes; multiple post-translational modifications of PTRF provide mechanistic bases for its regulation of rDNA transcription; this caveolae-independent nuclear function explains the lipodystrophy phenotype in PTRF-deficient mice and humans.\",\n      \"method\": \"rDNA transcription assays in mature adipocytes, analysis in PTRF-deficient mice, post-translational modification mapping\",\n      \"journal\": \"eLife\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — multiple orthogonal methods linking PTMs to rDNA transcription function\",\n      \"pmids\": [\"27528195\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"SOCS3 localizes to the plasma membrane through interaction with cavin-1; deletion of SOCS3 reduces cavin-1 and caveolin-1 protein expression and reduces caveola abundance in endothelial cells; the cavin-1/SOCS3 interaction is essential for SOCS3-dependent inhibition of IL-6 signaling by cyclic AMP.\",\n      \"method\": \"Biochemical interaction studies, confocal imaging, SOCS3 knockout cells, cytokine signaling assays\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal interaction and functional epistasis with multiple methods\",\n      \"pmids\": [\"29330478\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Cavin3 is targeted to caveolae by cavin1 where it interacts with the scaffolding domain of caveolin1 to promote caveolae dynamics; the N-terminal region of cavin3 binds a trimer of the cavin1 N-terminus in competition with cavin2, demonstrating distinct subcomplexes; loss of cavin3 increases stable caveolae and decreases transiently membrane-associated caveolae.\",\n      \"method\": \"Co-immunoprecipitation, TIRF/live-cell imaging, N-terminal binding competition assays, cavin3 KD cells\",\n      \"journal\": \"Journal of cell science\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP plus live imaging with functional consequence\",\n      \"pmids\": [\"25588833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"Purified Cavin1 forms 60S complexes that adopt a flexible, net-like protein mesh forming polyhedral lattices on phosphatidylserine-containing vesicles; the two coiled-coil domains mediate distinct assembly steps; positive residues around the C-terminal coiled-coil domain are required for membrane binding; caveolin 8S oligomers form disc-shaped arrangements consistent with occupying the faces of caveolar polyhedra.\",\n      \"method\": \"Electron cryotomography, in vitro reconstitution on liposomes, coiled-coil domain mutagenesis, purified protein structural analysis\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — reconstitution, structural analysis by cryo-ET, and mutagenesis in one study\",\n      \"pmids\": [\"27834731\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2016,\n      \"finding\": \"ROR1 functions as a scaffold for cavin-1 and caveolin-1 at the plasma membrane in a kinase-independent manner, facilitating their interaction and preventing lysosomal degradation of caveolin-1, thereby sustaining caveolae structures and pro-survival AKT signaling.\",\n      \"method\": \"Co-immunoprecipitation, immunofluorescence, ROR1 mutant expression, lysosomal inhibitor experiments\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal Co-IP, kinase-dead mutant, multiple inhibitor experiments\",\n      \"pmids\": [\"26725982\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"The N-terminal leucine-zipper motif of PTRF/Cavin1 is essential and sufficient for its caveolae association at the plasma membrane, counteracting its nuclear localization sequence (AA 235-251); deletion of this motif causes exclusive nuclear localization; caveolae-associated PTRF is required for its role in cell migration.\",\n      \"method\": \"Deletion mutant expression, live-cell fluorescence imaging, fusion protein nuclear export assay, MEF migration assay with PTRF mutant rescue\",\n      \"journal\": \"Biochemical and biophysical research communications\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — domain mutagenesis with functional consequence, single lab\",\n      \"pmids\": [\"25514038\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"High glucose promotes LDL transcytosis across endothelial cells by inhibiting the AMPK-mTOR-PIK3C3 pathway, which suppresses CAV1-CAVIN1-LC3B-mediated autophagic degradation of CAV1, leading to CAV1 accumulation, more caveolae formation, and increased LDL transcytosis.\",\n      \"method\": \"siRNA knockdown, AMPK/mTOR/PIK3C3 pathway inhibition, LDL transcytosis assay, autophagy flux analysis, immunoblotting\",\n      \"journal\": \"Autophagy\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — multiple pathway inhibition experiments with defined mechanistic sequence, single lab\",\n      \"pmids\": [\"31448673\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2019,\n      \"finding\": \"Cavin-1 is acutely translocated to focal complex compartments upon insulin stimulation, where it regulates focal complex formation through interaction with paxillin; loss of cavin-1 impairs focal complex remodeling and focal adhesion formation and causes a mechanical stress response with activation of proinflammatory and senescence/apoptosis pathways.\",\n      \"method\": \"Cavin-1 knockout mice, subcellular fractionation, immunoblotting, co-immunoprecipitation with paxillin, insulin stimulation assays\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — KO mouse with biochemical interaction identified, single lab\",\n      \"pmids\": [\"31126986\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Caveolin-1 and cavin1 individually sort distinct plasma membrane lipids; intact caveolar structures composed of both proteins generate a unique lipid nano-environment with selectivity for specific lipid headgroups and acyl chains.\",\n      \"method\": \"Quantitative nanoscale lipid mapping (STED-based), molecular dynamic simulations, genome-edited cells lacking CAV1 or cavin1\",\n      \"journal\": \"The Journal of cell biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1-2 — quantitative nanoscale lipid mapping plus MD simulations in genome-edited cells\",\n      \"pmids\": [\"33496726\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PTRF/Cavin1 acts as a novel RNA-binding protein that stabilizes lncRNA NEAT1, which in turn suppresses UBXN1 and activates NF-κB, driving PD-L1 transcription and promoting immune evasion in glioblastoma.\",\n      \"method\": \"RIP-Seq, RIP assay, ChIP, co-immunoprecipitation, qRT-PCR, PD-L1 reporter assay\",\n      \"journal\": \"Frontiers in immunology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — RIP-Seq combined with ChIP and functional signaling assays, single lab\",\n      \"pmids\": [\"35069587\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Membrane insertion of Cavin1 occurs via PI(4,5)P2-dependent adsorption of the trimeric helical region 1 (HR1) followed by partial separation and membrane insertion of individual helices; insertion kinetics are enhanced by flanking negatively charged disordered regions important for co-assembly with Caveolin1 in living cells.\",\n      \"method\": \"Model membrane biophysics, liposome binding assays, computational modeling, mutagenesis, live-cell imaging of Cavin1-Caveolin1 co-assembly\",\n      \"journal\": \"PNAS\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 — in vitro reconstitution with model membranes, computational modeling, and validated in cells\",\n      \"pmids\": [\"35696574\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Oxidative stress triggers lipid peroxidation and caveolar disassembly, releasing CAVIN1 from caveolae; released cytoplasmic CAVIN1 directly interacts with NRF2 and facilitates its degradation, thereby maintaining cellular susceptibility to oxidative-stress-induced cell death (ferroptosis); CAVIN1-null cells show impaired NRF2 negative regulation and resistance to lipid-peroxidation-induced ferroptosis.\",\n      \"method\": \"Quantitative whole-cell proteomics of genome-edited CAVIN1-null cells, co-immunoprecipitation of CAVIN1–NRF2, live-cell caveolae imaging, zebrafish wound model\",\n      \"journal\": \"Developmental cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — genome-edited cells, quantitative proteomics, reciprocal co-IP, in vivo zebrafish model\",\n      \"pmids\": [\"36858041\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"Caveola deformation (by osmotic stress) causes relocalization of cavin-1 to the nucleus, altering global transcription and translation; cavin-1 levels affect cytosolic RNA levels and the ability to form stress granules and p-bodies; Cav1-Gαq contact changes upon stimulation also trigger cavin-1 relocalization.\",\n      \"method\": \"Osmotic stress experiments, cavin-1 KO cell line, live-cell imaging, stress granule/p-body quantification, RNA level analysis\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — KO cell line with multiple phenotypic readouts, single lab\",\n      \"pmids\": [\"35513070\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"UBE2O ubiquitinates PTRF/CAVIN1 directly and inhibits its effects on exosome secretion by decreasing caveolae formation; SDPR/CAVIN2 interacts with both UBE2O and PTRF and promotes PTRF expression in exosomes; UBE2O decreases exosome secretion and downregulates exosomal PTRF secretion.\",\n      \"method\": \"Exogenous and endogenous co-immunoprecipitation, ubiquitination assays, ultracentrifugation exosome isolation, nanoparticle tracking analysis, electron microscopy\",\n      \"journal\": \"Cell communication and signaling\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — ubiquitination assay plus co-IP and functional exosome readouts, single lab\",\n      \"pmids\": [\"36443833\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2022,\n      \"finding\": \"PTRF/Cavin1 stabilizes cPLA2 by decreasing its proteasome-mediated degradation, resulting in increased cPLA2 activity and remodeled phospholipid composition in glioblastoma cells; this promotes tumor proliferation and suppresses CD8+ tumor-infiltrating lymphocytes.\",\n      \"method\": \"Co-immunoprecipitation, ubiquitination/proteasome inhibitor assays, nontargeted metabolomics, lipidomics, in vivo xenograft and intracranial tumor models\",\n      \"journal\": \"Neuro-oncology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — proteasome assay plus metabolomics with in vivo validation, single lab\",\n      \"pmids\": [\"33140095\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"CAVIN1 controls hERG potassium channel dynamics at the cardiac plasma membrane; elevated CAVIN1 promotes sotalol-induced translocation of hERG from the plasma membrane to cytoskeleton-associated fractions, reducing IKr and prolonging repolarization; CAVIN1 knockdown abrogates this translocation and reduces susceptibility to drug-induced long QT.\",\n      \"method\": \"iPS-CM electrophysiology, siRNA knockdown, adenoviral CAVIN1 overexpression, cellular hERG distribution imaging, sotalol/E4031/vandetanib/clarithromycin treatments\",\n      \"journal\": \"Circulation\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal gain- and loss-of-function in patient-derived iPS-CMs with electrophysiological readout\",\n      \"pmids\": [\"38682330\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Cavin-1 competes with BMPR2 for binding to the scaffolding domain of Caveolin-1; hypoxia enhances the Cavin-1/CAV1 interaction while attenuating the CAV1/BMPR2 interaction and BMPR2 membrane localization; Cavin-1 reduces BMPR2 membrane localization and Smad signal transduction in pulmonary artery endothelial cells; Cavin-1 knockdown is resistant to CAV1-induced pulmonary hypertension in vivo.\",\n      \"method\": \"Co-immunoprecipitation of CAV1/Cavin-1/BMPR2 complexes, domain mapping, hypoxia experiments in PAECs, Cavin-1 knockdown in vivo pulmonary hypertension model\",\n      \"journal\": \"Communications biology\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 — reciprocal co-IP with domain mapping, plus in vivo epistasis confirmation\",\n      \"pmids\": [\"38182755\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2020,\n      \"finding\": \"Cavin-1 deficiency inhibits the RhoA-ROCK2-LIMK-Cofilin signaling pathway and suppresses cytoskeletal dynamics in liver sinusoidal endothelial cells, causing reduction of fenestrae and impaired liver permeability leading to defective hepatic glycogen metabolism and neonatal hypoglycemia; F-actin depolymerization with latrunculin A rescues fenestration defects.\",\n      \"method\": \"Cavin1 KO mice (C57BL/6J), electron microscopy, signaling pathway analysis, latrunculin A rescue experiment\",\n      \"journal\": \"Advanced science\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2-3 — KO mouse with pathway analysis and pharmacological rescue, single lab\",\n      \"pmids\": [\"33042738\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"CAVIN1/PTRF is a multifunctional scaffolding protein that: (1) is essential for caveola biogenesis by forming a flexible polyhedral coat (via coiled-coil-mediated oligomerization and PI(4,5)P2-dependent membrane insertion) that stabilizes caveolin oligomers and prevents their lysosomal degradation; (2) in the nucleus promotes RNA Polymerase I transcript release and rDNA re-initiation by interacting with TTF-I, Pol I, and nascent pre-rRNA; (3) upon caveolar disassembly (triggered by mechanical, metabolic, or oxidative stimuli) translocates to the nucleus or cytosol to regulate NRF2 stability, focal adhesion remodeling via paxillin, and rRNA transcription; (4) interacts with SOCS3 to anchor cytokine-signaling inhibition at the plasma membrane; competes with BMPR2 for caveolin-1 scaffolding domain binding to modulate BMP/Smad signaling; docks MG53 at membrane injury sites for membrane repair; and controls hERG channel membrane dynamics in cardiomyocytes.\"\n}\n```","stage2_raw":"```json\n{\n  \"mechanistic_narrative\": \"CAVIN1 (PTRF) is a multifunctional scaffolding protein essential for caveola biogenesis and ribosomal RNA transcription, with additional signaling roles that are dynamically regulated by its redistribution between the plasma membrane, cytosol, and nucleus. CAVIN1 forms flexible polyhedral coat lattices on membranes through coiled-coil-mediated oligomerization and PI(4,5)P2-dependent membrane insertion, stabilizing caveolin oligomers and preventing their lysosomal degradation; loss of CAVIN1 abolishes morphologically identifiable caveolae and reduces caveolin protein levels in all tissues examined [PMID:18191225, PMID:18840361, PMID:27834731, PMID:35696574]. In the nucleus, CAVIN1 dissociates paused RNA Polymerase I ternary complexes by interacting with TTF-I, Pol I, and nascent pre-rRNA, thereby promoting transcript release and rDNA reinitiation to augment ribosomal RNA synthesis [PMID:9582279, PMID:11139612, PMID:27528195]. Upon caveolar disassembly triggered by mechanical, metabolic, or oxidative stimuli, released CAVIN1 translocates to cytosol or nucleus where it facilitates NRF2 degradation to regulate ferroptosis susceptibility, remodels focal adhesions via paxillin interaction, competes with BMPR2 for caveolin-1 scaffolding domain binding to modulate BMP/Smad signaling, controls hERG channel membrane dynamics in cardiomyocytes, and anchors SOCS3 at caveolae to inhibit cytokine signaling [PMID:36858041, PMID:31126986, PMID:38182755, PMID:38682330, PMID:29330478]. Loss-of-function mutations in CAVIN1 cause a congenital generalized lipodystrophy with muscular dystrophy due to secondary deficiency and mislocalization of all three caveolin isoforms [PMID:19726876, PMID:20300641].\",\n  \"teleology\": [\n    {\n      \"year\": 1998,\n      \"claim\": \"The molecular function of PTRF was established: it dissociates paused RNA Polymerase I ternary complexes by interacting with TTF-I, Pol I, and the 3′ end of nascent pre-rRNA, resolving how rDNA transcription termination is completed.\",\n      \"evidence\": \"In vitro transcription release assay with recombinant PTRF and RNA-binding mutants\",\n      \"pmids\": [\"9582279\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"In vivo relevance of transcript release not yet shown\", \"Structural basis of PTRF–Pol I interaction unknown\", \"Post-translational regulation of this activity not addressed\"]\n    },\n    {\n      \"year\": 1999,\n      \"claim\": \"The specificity of PTRF-mediated Pol I release was defined: PTRF acts only on termination-factor-paused complexes (TTF-I/Reb1p) and cannot release Pol I stalled by heterologous blocks, establishing it as a termination-coupled factor rather than a general release factor.\",\n      \"evidence\": \"In vitro transcription with immobilized templates and cross-species (mouse/yeast) termination factor comparison\",\n      \"pmids\": [\"10589839\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether PTRF is required for all Pol I termination events in vivo unknown\", \"Mechanism of specificity (direct recognition of TTF-I vs. paused complex conformation) unresolved\"]\n    },\n    {\n      \"year\": 2001,\n      \"claim\": \"PTRF was shown to facilitate Pol I reinitiation after transcript release, linking its activity to augmented rRNA synthesis rather than merely termination; phosphorylation was identified as a regulatory mechanism governing active vs. inactive PTRF pools.\",\n      \"evidence\": \"Multiple-round in vitro transcription in a PTRF-depleted reconstituted system with phosphorylation analysis\",\n      \"pmids\": [\"11139612\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Identity of kinases/phosphatases regulating PTRF unknown\", \"Physiological stimuli controlling PTRF phosphorylation not identified\"]\n    },\n    {\n      \"year\": 2004,\n      \"claim\": \"PTRF was unexpectedly identified as a major cytosolic coat protein of caveolae in adipocytes, revealing a second subcellular site of action; specific phosphorylation sites and calpain-cleavage sites were mapped, suggesting regulated proteolytic processing.\",\n      \"evidence\": \"Vectorial proteomics with nanospray-TOF MS on sealed caveolar vesicles from human adipocytes, confocal co-localization with caveolin\",\n      \"pmids\": [\"15242332\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Functional role of PTRF at caveolae not yet demonstrated\", \"Significance of calpain cleavage for PTRF function unknown\"]\n    },\n    {\n      \"year\": 2008,\n      \"claim\": \"CAVIN1 was established as essential and sufficient for caveola biogenesis: its loss abolishes caveolae in all tissues, causes caveolin mislocalization and lysosomal degradation (despite normal mRNA), and its re-expression rescues caveolae in caveola-deficient cells — fundamentally redefining caveola assembly as requiring a coat protein beyond caveolins alone.\",\n      \"evidence\": \"siRNA knockdown and ectopic expression in PC3 cells, FRAP, EM; global Cavin1 knockout mice with EM, immunoblotting, and qRT-PCR\",\n      \"pmids\": [\"18191225\", \"18840361\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Molecular mechanism of caveolin stabilization by CAVIN1 unknown\", \"Whether CAVIN1 directly contacts caveolins or acts indirectly unresolved\", \"Stoichiometry of coat complex undetermined\"]\n    },\n    {\n      \"year\": 2009,\n      \"claim\": \"Human loss-of-function PTRF mutations were shown to cause congenital generalized lipodystrophy with muscular dystrophy through secondary deficiency and mislocalization of all three caveolins, confirming the caveola-biogenesis role in human disease and establishing a direct disease link.\",\n      \"evidence\": \"Patient muscle biopsies, ectopic mutant PTRF expression in myoblasts, co-immunoprecipitation, rescue in patient fibroblasts with EM and AFM\",\n      \"pmids\": [\"19726876\", \"20300641\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Genotype–phenotype correlation across different PTRF mutations incomplete\", \"Relative contributions of caveolar vs. nuclear PTRF functions to lipodystrophy phenotype unclear\"]\n    },\n    {\n      \"year\": 2011,\n      \"claim\": \"CAVIN1 was found to participate in diverse cellular processes beyond caveola structure — membrane repair (by docking MG53 at injury sites), cellular senescence (by sequestering Mdm2 at caveolae to activate p53/p21), and dynamic nuclear-to-cytoplasmic translocation during senescence — revealing it as a signaling hub whose function depends on subcellular redistribution.\",\n      \"evidence\": \"RNAi, mutant PTRF expression, live-cell membrane repair imaging, co-IP with MG53; overexpression/shRNA with EM, luciferase reporter, subcellular fractionation for senescence pathway\",\n      \"pmids\": [\"21343302\", \"21705337\", \"21445100\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How caveolar disassembly is sensed and triggers CAVIN1 release unknown\", \"Direct mechanism of Mdm2 sequestration not structurally characterized\", \"MG53–CAVIN1 interaction domain not mapped\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"The N-terminal leucine-zipper motif was identified as essential and sufficient for caveolae targeting, counteracting a central NLS, explaining the binary nuclear-vs-caveolar distribution; separately, CAVIN1's nuclear function in rRNA transcription was shown to be physiologically relevant in mature adipocytes responding to metabolic stress, providing a caveolae-independent explanation for lipodystrophy.\",\n      \"evidence\": \"Deletion mutant analysis with live-cell imaging and migration rescue; rDNA transcription assays in adipocytes with PTM mapping in PTRF-deficient mice\",\n      \"pmids\": [\"25514038\", \"27528195\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Signals that regulate the leucine-zipper/NLS competition in vivo not identified\", \"Which PTMs specifically control rDNA transcription function remain to be mapped to individual sites\"]\n    },\n    {\n      \"year\": 2016,\n      \"claim\": \"The structural basis of the CAVIN1 coat was resolved: purified CAVIN1 forms 60S complexes that assemble into flexible polyhedral lattices on membranes; two coiled-coil domains mediate distinct oligomerization and membrane-binding steps, and caveolin 8S oligomers occupy the faces of the polyhedra.\",\n      \"evidence\": \"Electron cryotomography and in vitro reconstitution on liposomes with coiled-coil domain mutagenesis\",\n      \"pmids\": [\"27834731\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Atomic-resolution structure of the coat not available\", \"How the coat accommodates different caveolar curvatures not explained\", \"Stoichiometry of cavin1/cavin2/cavin3 subcomplexes in the coat unknown\"]\n    },\n    {\n      \"year\": 2018,\n      \"claim\": \"CAVIN1 was shown to anchor SOCS3 at caveolae; the CAVIN1–SOCS3 interaction is essential for cAMP-induced inhibition of IL-6 signaling, establishing CAVIN1 as a platform for cytokine-signaling regulation at the plasma membrane.\",\n      \"evidence\": \"Reciprocal biochemical interaction, SOCS3 KO cells, confocal imaging, cytokine signaling assays in endothelial cells\",\n      \"pmids\": [\"29330478\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CAVIN1 recruits other SOCS family members unknown\", \"Structural basis of the SOCS3–CAVIN1 interface not determined\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"The membrane-insertion mechanism was resolved at the biophysical level: PI(4,5)P2-dependent adsorption of the trimeric HR1 domain is followed by partial helix separation and insertion, with flanking disordered regions enhancing kinetics and co-assembly with caveolin-1, providing a detailed model of how CAVIN1 senses membrane composition.\",\n      \"evidence\": \"Model membrane biophysics, liposome binding assays, computational modeling, mutagenesis validated in live cells\",\n      \"pmids\": [\"35696574\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"How PI(4,5)P2 levels dynamically regulate caveola assembly/disassembly in vivo not shown\", \"Whether other phosphoinositides modulate insertion unknown\"]\n    },\n    {\n      \"year\": 2022,\n      \"claim\": \"A major signaling output of caveolar disassembly was identified: released cytoplasmic CAVIN1 directly binds NRF2 and promotes its degradation, maintaining cellular sensitivity to ferroptosis; this established a caveolae-to-oxidative-stress response signaling axis.\",\n      \"evidence\": \"Quantitative proteomics in CAVIN1 KO cells, reciprocal co-IP of CAVIN1–NRF2, live-cell caveolae imaging, zebrafish wound model\",\n      \"pmids\": [\"36858041\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CAVIN1 promotes NRF2 degradation via KEAP1-dependent or -independent ubiquitination unknown\", \"Relative contribution of this pathway versus caveolar mechanoprotection to tissue homeostasis not quantified\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"CAVIN1 was placed in two new physiological contexts: it controls hERG potassium channel membrane dynamics in cardiomyocytes (affecting drug-induced QT prolongation), and it competes with BMPR2 for caveolin-1's scaffolding domain to modulate BMP/Smad signaling and pulmonary hypertension, extending the competition model for caveolin-1 interactions.\",\n      \"evidence\": \"iPS-CM electrophysiology with reciprocal gain/loss-of-function for hERG; co-IP domain mapping, hypoxia experiments in PAECs, and in vivo epistasis in pulmonary hypertension model for BMPR2\",\n      \"pmids\": [\"38682330\", \"38182755\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Whether CAVIN1-dependent hERG redistribution occurs via caveolar endocytosis or cytoskeletal sequestration is unresolved\", \"How hypoxia increases CAVIN1–CAV1 interaction mechanistically is unknown\", \"Therapeutic targetability of the CAVIN1–CAV1 competition not tested\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"Major open questions remain: the atomic-resolution structure of the CAVIN1 coat and its dynamic remodeling under force; the precise signals and kinases that switch CAVIN1 between caveolar, cytosolic, and nuclear pools; whether CAVIN1's diverse cytosolic signaling partners (NRF2, paxillin, MG53, SOCS3) compete or are spatiotemporally segregated; and how caveolar versus nuclear CAVIN1 functions differentially contribute to human lipodystrophy and cardiometabolic disease.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"No atomic-resolution structure of CAVIN1 coat or its individual domains\", \"Kinase(s) regulating nuclear–caveolar shuttling not identified\", \"Relative pathogenic contributions of caveolar vs. rRNA transcription defects in CAVIN1-linked lipodystrophy unknown\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0003723\", \"supporting_discovery_ids\": [0, 1, 25]},\n      {\"term_id\": \"GO:0005198\", \"supporting_discovery_ids\": [4, 5, 19, 26]},\n      {\"term_id\": \"GO:0060090\", \"supporting_discovery_ids\": [10, 17, 23, 32]},\n      {\"term_id\": \"GO:0008289\", \"supporting_discovery_ids\": [19, 24, 26]},\n      {\"term_id\": \"GO:0098772\", \"supporting_discovery_ids\": [11, 27, 31, 32]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005886\", \"supporting_discovery_ids\": [3, 4, 5, 19, 26]},\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [0, 12, 16, 21, 28]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [27, 28]},\n      {\"term_id\": \"GO:0031410\", \"supporting_discovery_ids\": [4, 22]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [0, 1, 2, 16]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [11, 17, 27, 32]},\n      {\"term_id\": \"R-HSA-8953854\", \"supporting_discovery_ids\": [0, 1, 2, 16]},\n      {\"term_id\": \"R-HSA-1852241\", \"supporting_discovery_ids\": [4, 5, 19, 26]},\n      {\"term_id\": \"R-HSA-9612973\", \"supporting_discovery_ids\": [22]},\n      {\"term_id\": \"R-HSA-5357801\", \"supporting_discovery_ids\": [11, 27]},\n      {\"term_id\": \"R-HSA-8953897\", \"supporting_discovery_ids\": [27, 28]}\n    ],\n    \"complexes\": [\n      \"Caveolar coat complex (cavin1/cavin2/cavin3 with caveolin oligomers)\"\n    ],\n    \"partners\": [\n      \"CAV1\",\n      \"CAV2\",\n      \"CAV3\",\n      \"SOCS3\",\n      \"TRIM72\",\n      \"PXN\",\n      \"NFE2L2\",\n      \"BMPR2\"\n    ],\n    \"other_free_text\": []\n  }\n}\n```"}